Functional	O
roles	O
of	O
the	O
transcription	B-protein
factor	I-protein
Oct-2A	I-protein
and	O
the	O
high	B-protein
mobility	I-protein
group	I-protein
protein	I-protein
I/Y	B-protein
in	O
HLA-DRA	B-DNA
gene	I-DNA
expression	O
.	O

The	O
class	B-DNA
II	I-DNA
major	I-DNA
histocompatibility	I-DNA
complex	I-DNA
gene	I-DNA
HLA-DRA	B-DNA
is	O
expressed	O
in	O
B	B-cell_type
cells	I-cell_type
,	O
activated	O
T	B-cell_type
lymphocytes	I-cell_type
,	O
and	O
in	O
antigen-presenting	B-cell_type
cells	I-cell_type
.	O

In	O
addition	O
,	O
HLA-DRA	B-DNA
gene	I-DNA
expression	O
is	O
inducible	O
in	O
a	O
variety	O
of	O
cell	O
types	O
by	O
interferon-gamma	B-protein
(	O
IFN-gamma	B-protein
)	O
.	O

Here	O
we	O
show	O
that	O
the	O
lymphoid-specific	B-protein
transcription	I-protein
factor	I-protein
Oct-2A	I-protein
plays	O
a	O
critical	O
role	O
in	O
HLA-DRA	B-DNA
gene	I-DNA
expression	O
in	O
class	B-cell_line
II-positive	I-cell_line
B	I-cell_line
cell	I-cell_line
lines	I-cell_line
,	O
and	O
that	O
the	O
high	B-protein
mobility	I-protein
group	I-protein
protein	I-protein
(	O
HMG	B-protein
)	O
I/Y	B-protein
binds	O
to	O
multiple	O
sites	O
within	O
the	O
DRA	B-DNA
promoter	I-DNA
,	O
including	O
the	O
Oct-2A	B-DNA
binding	I-DNA
site	I-DNA
.	O

Coexpression	O
of	O
HMG	B-protein
I/Y	I-protein
and	O
Oct-2	B-protein
in	O
cell	B-cell_line
lines	I-cell_line
lacking	O
Oct-2	B-protein
results	O
in	O
high	O
levels	O
of	O
HLA-DRA	B-DNA
gene	I-DNA
expression	O
,	O
and	O
in	O
vitro	O
DNA-binding	O
studies	O
reveal	O
that	O
HMG	O
I/Y	B-protein
stimulates	O
Oct-2A	B-protein
binding	O
to	O
the	O
HLA-DRA	B-DNA
promoter	I-DNA
.	O

Thus	O
,	O
Oct-2A	B-protein
and	O
HMG	B-protein
I/Y	I-protein
may	O
synergize	O
to	O
activate	O
HLA-DRA	B-DNA
expression	O
in	O
B	B-cell_type
cells	I-cell_type
.	O

By	O
contrast	O
,	O
Oct-2A	B-protein
is	O
not	O
involved	O
in	O
the	O
IFN-gamma	B-protein
induction	O
of	O
the	O
HLA-DRA	B-DNA
gene	I-DNA
in	O
HeLa	B-cell_line
cells	I-cell_line
,	O
but	O
antisense	B-DNA
HMG	I-DNA
I/Y	I-DNA
dramatically	O
decreases	O
the	O
level	O
of	O
induction	O
.	O

We	O
conclude	O
that	O
distinct	O
sets	O
of	O
transcription	B-protein
factors	I-protein
are	O
involved	O
in	O
the	O
two	O
modes	O
of	O
HLA-DRA	B-DNA
expression	O
,	O
and	O
that	O
HMG	B-protein
I/Y	I-protein
may	O
be	O
important	O
for	O
B	O
cell-specific	O
expression	O
,	O
and	O
is	O
essential	O
for	O
IFN-gamma	B-protein
induction	O
.	O

Functional	NULL
Roles	NULL
of	NULL
the	NULL
Transcription	NULL
Factor	NULL
Oct-2A	NULL
and	NULL
the	NULL
High	NULL
Mobility	NULL
Group	NULL
Protein	NULL
I/Y	NULL
in	NULL
HLA-DRA	NULL
Gene	NULL
Expression	NULL
By	NULL
Sarki	NULL
Abba	NULL
Abdulkadir	NULL
,	NULL
*	NULL
}	NULL
Srikant	NULL
Krishna	NULL
,	NULL
*	NULL
``	NULL
$	NULL
Dimitris	NULL
Thanos	NULL
,	NULL
Tom	NULL
Maniatis	NULL
,	NULL
Jack	NULL
L.	NULL
Strominger	NULL
,	NULL
``	NULL
and	NULL
Santa	NULL
Jeremy	NULL
Ono*tS	NULL
From	NULL
the	NULL
*Departments	NULL
of	NULL
Medicine	NULL
and	NULL
Pathology	NULL
,	NULL
Lucille	NULL
P.	NULL
Markey	NULL
Graduate	NULL
Program	NULL
in	NULL
Cellular	NULL
and	NULL
Molecular	NULL
Medicine	NULL
,	NULL
Graduate	NULL
Program	NULL
in	NULL
Immunology	NULL
,	NULL
The	NULL
Johns	NULL
Hopkins	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Baltimore	NULL
,	NULL
Maryland	NULL
21224	NULL
;	NULL
tDepartment	NULL
of	NULL
Molecular	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
The	NULL
Johns	NULL
Hopkins	NULL
University	NULL
School	NULL
of	NULL
Public	NULL
Health	NULL
,	NULL
Baltimore	NULL
,	NULL
Maryland	NULL
21205	NULL
;	NULL
Department	NULL
of	NULL
Biology	NULL
,	NULL
The	NULL
Johns	NULL
Hopkins	NULL
University	NULL
School	NULL
of	NULL
Arts	NULL
and	NULL
Sciences	NULL
,	NULL
Baltimore	NULL
,	NULL
Maryland	NULL
21218	NULL
;	NULL
and	NULL
Department	NULL
of	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
,	NULL
Harvard	NULL
University	NULL
,	NULL
Cambridge	NULL
,	NULL
Massachusetts	NULL
02138	NULL
Summary	NULL
The	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
complex	NULL
gene	NULL
HLA-DR	NULL
A	NULL
is	NULL
expressed	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
activated	NULL
T	NULL
lymphocytes	NULL
,	NULL
and	NULL
in	NULL
antigen-presenting	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
HLA-DRA	NULL
gene	NULL
expression	NULL
is	NULL
inducible	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
by	NULL
interferon-y	NULL
(	NULL
IFN-y	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
the	NULL
lymphoid-specific	NULL
transcription	NULL
factor	NULL
Oct-2A	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
HLA-DRA	NULL
gene	NULL
expression	NULL
in	NULL
class	NULL
II-positive	NULL
B	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
that	NULL
the	NULL
high	NULL
mobility	NULL
group	NULL
protein	NULL
(	NULL
HMG	NULL
)	NULL
I/Y	NULL
binds	NULL
to	NULL
multiple	NULL
sites	NULL
within	NULL
the	NULL
DRA	NULL
promoter	NULL
,	NULL
including	NULL
the	NULL
Oct-2A	NULL
binding	NULL
site	NULL
.	NULL

Coexpression	NULL
of	NULL
HMG	NULL
I/Y	NULL
and	NULL
Oct-2	NULL
in	NULL
cell	NULL
lines	NULL
lacking	NULL
Oct-2	NULL
results	NULL
in	NULL
high	NULL
levels	NULL
of	NULL
HLA-DRA	NULL
gene	NULL
expression	NULL
,	NULL
and	NULL
in	NULL
vitro	NULL
DNA-binding	NULL
studies	NULL
reveal	NULL
that	NULL
HMG	NULL
I/Y	NULL
stimulates	NULL
Oct-2A	NULL
binding	NULL
to	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
.	NULL

Thus	NULL
,	NULL
Oct-2A	NULL
and	NULL
HMG	NULL
I/Y	NULL
may	NULL
synergize	NULL
to	NULL
activate	NULL
HLA-DRA	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
Oct-2A	NULL
is	NULL
not	NULL
involved	NULL
in	NULL
the	NULL
IFN-y	NULL
induction	NULL
of	NULL
the	NULL
HLA-DRA	NULL
gene	NULL
in	NULL
Hela	NULL
cells	NULL
,	NULL
but	NULL
antisense	NULL
HMG	NULL
I/Y	NULL
dramatically	NULL
decreases	NULL
the	NULL
level	NULL
of	NULL
induction	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
distinct	NULL
sets	NULL
of	NULL
transcription	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
two	NULL
modes	NULL
of	NULL
HLA-DRA	NULL
expression	NULL
,	NULL
and	NULL
that	NULL
HMG	NULL
I/Y	NULL
may	NULL
be	NULL
important	NULL
for	NULL
B	NULL
cell-specific	NULL
expression	NULL
,	NULL
and	NULL
is	NULL
essential	NULL
for	NULL
IFN-y	NULL
induction	NULL
.	NULL

lass	NULL
II	NULL
molecules	NULL
of	NULL
the	NULL
MHC	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
the	NULL
immune	NULL
response	NULL
by	NULL
presenting	NULL
processed	NULL
peptides	NULL
of	NULL
foreign	NULL
antigen	NULL
to	NULL
T	NULL
helper	NULL
cells	NULL
and	NULL
by	NULL
participating	NULL
in	NULL
the	NULL
thymic	NULL
selection	NULL
of	NULL
T	NULL
lymphocytes	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
&	NULL
and	NULL
3	NULL
chains	NULL
of	NULL
the	NULL
heterodimeric	NULL
MHC	NULL
class	NULL
II	NULL
molecules	NULL
are	NULL
encoded	NULL
by	NULL
genes	NULL
located	NULL
within	NULL
the	NULL
HLA-DR	NULL
,	NULL
-DP	NULL
,	NULL
and	NULL
-DQ	NULL
loci	NULL
in	NULL
human	NULL
(	NULL
2	NULL
)	NULL
,	NULL
with	NULL
each	NULL
set	NULL
of	NULL
&	NULL
and	NULL
3	NULL
polypeptides	NULL
forming	NULL
a	NULL
distinct	NULL
class	NULL
II	NULL
isotype	NULL
.	NULL

The	NULL
different	NULL
class	NULL
II	NULL
isotypes	NULL
are	NULL
generally	NULL
expressed	NULL
coordinately	NULL
,	NULL
although	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
this	NULL
is	NULL
not	NULL
always	NULL
the	NULL
case	NULL
in	NULL
vivo	NULL
(	NULL
3-5	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
molecules	NULL
is	NULL
ordinarily	NULL
restricted	NULL
to	NULL
cells	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
,	NULL
but	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
can	NULL
be	NULL
induced	NULL
to	NULL
express	NULL
MHC	NULL
class	NULL
II	NULL
molecules	NULL
by	NULL
several	NULL
stimuli	NULL
(	NULL
reviewed	NULL
in	NULL
6	NULL
)	NULL
.	NULL

Of	NULL
these	NULL
,	NULL
the	NULL
cytokine	NULL
IFN-y	NULL
is	NULL
among	NULL
the	NULL
most	NULL
potent	NULL
and	NULL
well	NULL
studied	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Aberrant	NULL
expression	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
molecules	NULL
may	NULL
be	NULL
important	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
autoimmune	NULL
disorders	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
while	NULL
defective	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
molecules	NULL
is	NULL
the	NULL
basis	NULL
for	NULL
a	NULL
subset	NULL
of	NULL
severe	NULL
combined	NULL
487	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

©	NULL
The	NULL
Rockefeller	NULL
University	NULL
Press	NULL
«	NULL
immunodeficiency	NULL
diseases	NULL
known	NULL
as	NULL
the	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
DNA	NULL
sequence	NULL
requirements	NULL
for	NULL
both	NULL
B	NULL
cell-specific	NULL
expression	NULL
and	NULL
IFN-y	NULL
induction	NULL
of	NULL
the	NULL
HLA	NULL
genes	NULL
reveal	NULL
a	NULL
complex	NULL
organization	NULL
of	NULL
regulatory	NULL
elements	NULL
(	NULL
reviewed	NULL
in	NULL
6	NULL
,	NULL
13	NULL
)	NULL
.	NULL

The	NULL
proximal	NULL
160	NULL
bp	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
gene	NULL
promoters	NULL
contain	NULL
conserved	NULL
DNA	NULL
elements	NULL
called	NULL
the	NULL
X	NULL
,	NULL
Y	NULL
,	NULL
and	NULL
Z/W/H	NULL
boxes	NULL
,	NULL
each	NULL
of	NULL
which	NULL
are	NULL
required	NULL
for	NULL
transcription	NULL
(	NULL
14-17	NULL
)	NULL
.	NULL

The	NULL
Y	NULL
box	NULL
is	NULL
an	NULL
inverted	NULL
CAAT	NULL
box	NULL
and	NULL
a	NULL
number	NULL
of	NULL
proteins	NULL
that	NULL
specifically	NULL
interact	NULL
with	NULL
it	NULL
have	NULL
been	NULL
identified	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

The	NULL
X	NULL
box	NULL
is	NULL
found	NULL
18-20	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
Y	NULL
box	NULL
.	NULL

The	NULL
sequences	NULL
separating	NULL
these	NULL
elements	NULL
are	NULL
variable	NULL
,	NULL
but	NULL
the	NULL
length	NULL
of	NULL
the	NULL
sequence	NULL
is	NULL
both	NULL
conserved	NULL
and	NULL
critical	NULL
for	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
genes	NULL
(	NULL
17	NULL
,	NULL
20	NULL
)	NULL
.	NULL

The	NULL
X	NULL
box	NULL
can	NULL
be	NULL
further	NULL
subdivided	NULL
into	NULL
two	NULL
motifs	NULL
:	NULL
the	NULL
X1	NULL
and	NULL
X2	NULL
boxes	NULL
,	NULL
which	NULL
bind	NULL
distinct	NULL
types	NULL
of	NULL
sequence-specific	NULL
DNA-binding	NULL
proteins	NULL
(	NULL
21-28	NULL
)	NULL
.	NULL

0022-1007/95/08/0487/14	NULL
$	NULL
2.00	NULL
Volume	NULL
182	NULL
-	NULL
August	NULL
1995	NULL
-	NULL
487-500	NULL
A	NULL
region	NULL
termed	NULL
W	NULL
,	NULL
which	NULL
contains	NULL
multiple	NULL
potential	NULL
control	NULL
elements	NULL
called	NULL
Z	NULL
,	NULL
H	NULL
,	NULL
V	NULL
,	NULL
or	NULL
S	NULL
,	NULL
exhibits	NULL
a	NULL
degree	NULL
of	NULL
sequence	NULL
conservation	NULL
when	NULL
the	NULL
different	NULL
class	NULL
II	NULL
MHC	NULL
sequences	NULL
are	NULL
aligned	NULL
(	NULL
29-34	NULL
)	NULL
.	NULL

An	NULL
additional	NULL
element	NULL
,	NULL
called	NULL
J	NULL
,	NULL
has	NULL
recently	NULL
been	NULL
described	NULL
,	NULL
which	NULL
appears	NULL
to	NULL
be	NULL
important	NULL
for	NULL
induction	NULL
of	NULL
different	NULL
class	NULL
II	NULL
MHC	NULL
genes	NULL
by	NULL
IFN-y	NULL
(	NULL
35	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
these	NULL
regulatory	NULL
elements	NULL
,	NULL
which	NULL
are	NULL
found	NULL
in	NULL
all	NULL
of	NULL
the	NULL
class	NULL
II	NULL
genes	NULL
from	NULL
mice	NULL
and	NULL
humans	NULL
,	NULL
the	NULL
human	NULL
DRA	NULL
and	NULL
DQB	NULL
gene	NULL
promoters	NULL
contain	NULL
a	NULL
consensus	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
transcriptional	NULL
activators	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
(	NULL
14	NULL
,	NULL
36-40	NULL
)	NULL
.	NULL

The	NULL
)	NULL
proximal	NULL
promoter	NULL
is	NULL
sufficient	NULL
in	NULL
directing	NULL
both	NULL
B	NULL
cell-specific	NULL
and	NULL
inducible	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
DNA-binding	NULL
proteins	NULL
that	NULL
interact	NULL
with	NULL
conserved	NULL
class	NULL
II	NULL
MHC	NULL
regulatory	NULL
elements	NULL
in	NULL
vitro	NULL
are	NULL
ubiquitously	NULL
expressed	NULL
in	NULL
vivo	NULL
and	NULL
the	NULL
status	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
transcription	NULL
correlates	NULL
with	NULL
promoter	NULL
occupancy	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
of	NULL
the	NULL
DRA	NULL
promoter	NULL
in	NULL
uninduced	NULL
class	NULL
II-negative	NULL
Hela	NULL
cells	NULL
shows	NULL
little	NULL
protection	NULL
of	NULL
conserved	NULL
motifs	NULL
,	NULL
while	NULL
the	NULL
regulatory	NULL
DNA	NULL
elements	NULL
in	NULL
class	NULL
II-positive	NULL
B	NULL
cells	NULL
are	NULL
fully	NULL
protected	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
class	NULL
II	NULL
expression	NULL
by	NULL
treatment	NULL
of	NULL
HeLa	NULL
cells	NULL
in	NULL
IFN-y	NULL
leads	NULL
to	NULL
increased	NULL
protection	NULL
at	NULL
the	NULL
same	NULL
sites	NULL
as	NULL
those	NULL
protected	NULL
in	NULL
class	NULL
II	NULL
positive	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
octamer	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
HLA-DR	NULL
promoter	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
required	NULL
for	NULL
constitutive	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
but	NULL
not	NULL
for	NULL
IFN-y	NULL
induction	NULL
(	NULL
16	NULL
,	NULL
42	NULL
)	NULL
.	NULL

We	NULL
have	NULL
confirmed	NULL
these	NULL
findings	NULL
and	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
an	NULL
octamer-binding	NULL
site	NULL
in	NULL
the	NULL
HLA-DQB	NULL
promoter	NULL
(	NULL
38	NULL
)	NULL
,	NULL
is	NULL
not	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
have	NULL
carried	NULL
out	NULL
antisense	NULL
RNA	NULL
experiments	NULL
to	NULL
show	NULL
that	NULL
the	NULL
Oct-2A	NULL
protein	NULL
is	NULL
required	NULL
for	NULL
B	NULL
cell-specific	NULL
expression	NULL
of	NULL
the	NULL
endogenous	NULL
HLA-DRA	NULL
gene	NULL
.	NULL

The	NULL
high	NULL
mobility	NULL
group	NULL
(	NULL
HMG	NULL
)	NULL
!	NULL

protein	NULL
HMG	NULL
I/Y	NULL
was	NULL
previously	NULL
shown	NULL
to	NULL
be	NULL
required	NULL
for	NULL
virus	NULL
induction	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

HMG	NULL
I/Y	NULL
facilitates	NULL
the	NULL
binding	NULL
of	NULL
two	NULL
distinct	NULL
transcription	NULL
factors	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
ATF-2	NULL
,	NULL
and	NULL
also	NULL
appears	NULL
to	NULL
function	NULL
as	NULL
an	NULL
architectural	NULL
component	NULL
of	NULL
an	NULL
inducible	NULL
enhancer	NULL
complex	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
show	NULL
that	NULL
HMG	NULL
I/Y	NULL
binds	NULL
to	NULL
multiple	NULL
sites	NULL
within	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
,	NULL
that	NULL
HMG	NULL
I/Y	NULL
and	NULL
Oct-2A	NULL
synergize	NULL
in	NULL
transfection	NULL
experiments	NULL
and	NULL
that	NULL
the	NULL
two	NULL
proteins	NULL
cooperatively	NULL
bind	NULL
to	NULL
DNA	NULL
in	NULL
vitro	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
using	NULL
antisense	NULL
RNA	NULL
experiments	NULL
we	NULL
show	NULL
that	NULL
HMG	NULL
I/	NULL
Y	NULL
is	NULL
required	NULL
for	NULL
IFN-y	NULL
induction	NULL
of	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
.	NULL

Thus	NULL
,	NULL
HMG	NULL
I/Y	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
assembly	NULL
of	NULL
two	NULL
distinct	NULL
transcriptional	NULL
activation	NULL
complexes	NULL
on	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
,	NULL
one	NULL
for	NULL
B	NULL
cell-specific	NULL
expression	NULL
,	NULL
and	NULL
the	NULL
other	NULL
for	NULL
IFN-y	NULL
inducible	NULL
expression	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
Culture	NULL
and	NULL
Flow	NULL
Cytometry	NULL
.	NULL

Hela	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
DMEM	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
gluta-mine	NULL
,	NULL
and	NULL
antibiotics	NULL
.	NULL

Human	NULL
Raji	NULL
,	NULL
Jijoye	NULL
,	NULL
and	NULL
Jurkat	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
gluta-	NULL
1	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyl	NULL
transferase	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
HMG	NULL
,	NULL
high	NULL
mobility	NULL
group	NULL
.	NULL

mine	NULL
,	NULL
and	NULL
antibiotics	NULL
.	NULL

For	NULL
induction	NULL
with	NULL
IFN-y	NULL
HeLa	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
recombinant	NULL
IFN-y	NULL
(	NULL
Genentech	NULL
,	NULL
South	NULL
San	NULL
Fran-cisco	NULL
,	NULL
CA	NULL
)	NULL
at	NULL
500	NULL
U/ml	NULL
for	NULL
48	NULL
h.	NULL
The	NULL
following	NULL
monoclonal	NULL
antibodies	NULL
were	NULL
used	NULL
for	NULL
flow	NULL
cytometric	NULL
analysis	NULL
:	NULL
LB3.1	NULL
(	NULL
anti-DR	NULL
)	NULL
,	NULL
B7/21	NULL
(	NULL
anti-DP	NULL
)	NULL
,	NULL
and	NULL
Genox	NULL
3.53	NULL
(	NULL
anti-DQ	NULL
)	NULL
.	NULL

These	NULL
antibodies	NULL
are	NULL
all	NULL
of	NULL
the	NULL
IgGA	NULL
subclass	NULL
.	NULL

Recombinant	NULL
DNA	NULL
and	NULL
Proteins	NULL
.	NULL

'The	NULL
plasmids	NULL
DRA300CAT	NULL
and	NULL
DQB2500CAT	NULL
have	NULL
been	NULL
described	NULL
(	NULL
27	NULL
)	NULL
.	NULL

A.S.	NULL
hXBP-1	NULL
and	NULL
a.s.	NULL
fos	NULL
.	NULL

plasmids	NULL
have	NULL
also	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
28	NULL
)	NULL
.	NULL

A.S.	NULL
oct1	NULL
and	NULL
A.S.	NULL
oct-2A	NULL
were	NULL
synthesized	NULL
by	NULL
subcloning	NULL
the	NULL
entire	NULL
Oct-1	NULL
or	NULL
Oct-2A	NULL
cDNAs	NULL
in	NULL
the	NULL
reverse	NULL
orientation	NULL
behind	NULL
the	NULL
CMV	NULL
promoter	NULL
in	NULL
the	NULL
pcDNA	NULL
cloning	NULL
vector	NULL
.	NULL

DRA300	NULL
mutant	NULL
pro-moter-chloramphenicol	NULL
acetyl	NULL
transferase	NULL
(	NULL
CAT	NULL
)	NULL
constructs	NULL
were	NULL
made	NULL
by	NULL
subcloning	NULL
the	NULL
mutated	NULL
promoter	NULL
fragments	NULL
from	NULL
the	NULL
Bluescript	NULL
constructs	NULL
(	NULL
Stratagene	NULL
Inc.	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
described	NULL
under	NULL
site-directed	NULL
mutagenesis	NULL
below	NULL
,	NULL
into	NULL
the	NULL
Xbal	NULL
site	NULL
of	NULL
the	NULL
promoterless	NULL
plasmid	NULL
pCAT	NULL
Basic	NULL
(	NULL
Promega	NULL
Corp.	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

All	NULL
constructs	NULL
were	NULL
confirmed	NULL
by	NULL
dideoxy	NULL
sequencing	NULL
.	NULL

Escherichia	NULL
coli	NULL
expressed	NULL
HMG	NULL
I/Y	NULL
protein	NULL
was	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Recombinant	NULL
Oct-2	NULL
protein	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
M.	NULL
Tanaka	NULL
(	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
)	NULL
.	NULL

Site-directed	NULL
Mutagenesis	NULL
.	NULL

_	NULL
All	NULL
site-specific	NULL
mutations	NULL
in	NULL
HMG	NULL
I/Y	NULL
binding	NULL
sites	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
using	NULL
as	NULL
template	NULL
the	NULL
BSDRA300	NULL
plasmid	NULL
(	NULL
26	NULL
)	NULL
.	NULL

To	NULL
mutagenize	NULL
the	NULL
octamer	NULL
motif	NULL
,	NULL
oligos	NULL
44a	NULL
:	NULL
(	NULL
5AGAGTAATTGATGGGCATTTTAATGG-3	NULL
)	NULL
and	NULL
44b	NULL
:	NULL
(	NULL
§5-CCATTAAAATGCCCATCAATTACTCT-	NULL
}	NULL
)	NULL
,	NULL
with	NULL
bold	NULL
type	NULL
denoting	NULL
mutated	NULL
bases	NULL
,	NULL
were	NULL
used	NULL
.	NULL

For	NULL
mutagenizing	NULL
the	NULL
AC-rich	NULL
D-box	NULL
region	NULL
,	NULL
oligos	NULL
45a	NULL
:	NULL
(	NULL
FATCTCAAAATATGGGTCTGATTGGCCA-3	NULL
)	NULL
and	NULL
45b	NULL
:	NULL
(	NULL
5'-TGGCCAATCAGACCCATATTTTGAGAT-3	NULL
)	NULL
were	NULL
used	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
mutagenizing	NULL
oligos	NULL
was	NULL
used	NULL
in	NULL
a	NULL
first	NULL
PCR	NULL
reaction	NULL
with	NULL
either	NULL
the	NULL
T3	NULL
or	NULL
the	NULL
T7	NULL
Bluescript	NULL
primers	NULL
.	NULL

The	NULL
two	NULL
PCR	NULL
products	NULL
were	NULL
purified	NULL
by	NULL
Geneclean	NULL
II	NULL
(	NULL
Bio	NULL
101	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
mixed	NULL
in	NULL
equimolar	NULL
amounts	NULL
and	NULL
used	NULL
in	NULL
a	NULL
third	NULL
PCR	NULL
reaction	NULL
with	NULL
the	NULL
T7	NULL
and	NULL
the	NULL
T3	NULL
primers	NULL
.	NULL

The	NULL
final	NULL
PCR	NULL
product	NULL
was	NULL
digested	NULL
with	NULL
EcoRI	NULL
and	NULL
HindIII	NULL
and	NULL
subcloned	NULL
into	NULL
the	NULL
EcoRI-HindIII	NULL
site	NULL
of	NULL
the	NULL
Bluescript	NULL
KS/+	NULL
plasmid	NULL
.	NULL

An	NULL
additional	NULL
mutant	NULL
:	NULL
(	NULL
5'-ATCTCCAGATATGGGTCTGATTGGCCA-3	NULL
)	NULL
was	NULL
generated	NULL
spuriously	NULL
.	NULL

Double	NULL
mutants	NULL
were	NULL
generated	NULL
by	NULL
exploiting	NULL
a	NULL
unique	NULL
Mscl	NULL
restriction	NULL
site	NULL
between	NULL
the	NULL
octamer	NULL
and	NULL
the	NULL
D	NULL
box	NULL
to	NULL
swap	NULL
fragments	NULL
between	NULL
the	NULL
single	NULL
mutants	NULL
.	NULL

All	NULL
mutations	NULL
were	NULL
confirmed	NULL
by	NULL
dideoxy	NULL
sequencing	NULL
.	NULL

Transfections	NULL
and	NULL
CAT	NULL
Assays	NULL
.	NULL

-	NULL
Jijoye	NULL
and	NULL
HeLa	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
lipofectamine	NULL
(	NULL
Gibco	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
,	NULL
while	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
the	NULL
DEAE	NULL
dextran	NULL
transfection	NULL
method	NULL
.	NULL

For	NULL
assessing	NULL
the	NULL
activity	NULL
of	NULL
mutant	NULL
DRA	NULL
promoters	NULL
,	NULL
Jijoye	NULL
and	NULL
Hela	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
the	NULL
mutant	NULL
promoter-CAT	NULL
constructs	NULL
.	NULL

The	NULL
B	NULL
galactosidase	NULL
expression	NULL
vector	NULL
,	NULL
pSV-O-gal	NULL
(	NULL
Promega	NULL
)	NULL
was	NULL
included	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
to	NULL
monitor	NULL
transfection	NULL
efficiency	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
made	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
normalized	NULL
for	NULL
-galactosidase	NULL
activity	NULL
,	NULL
and	NULL
used	NULL
in	NULL
CAT	NULL
assays	NULL
as	NULL
described	NULL
below	NULL
.	NULL

For	NULL
Jurkat	NULL
cells	NULL
,	NULL
10°	NULL
recipient	NULL
cells	NULL
were	NULL
washed	NULL
extensively	NULL
with	NULL
serum-free	NULL
media	NULL
.	NULL

20	NULL
ug	NULL
of	NULL
cesium	NULL
chloride-purified	NULL
,	NULL
supercoiled	NULL
plasmid	NULL
DNA	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
in	NULL
a	NULL
1-ml	NULL
vol	NULL
of	NULL
serum-free	NULL
RPMI	NULL
1640	NULL
containing	NULL
200	NULL
ug	NULL
of	NULL
DEAE	NULL
Dextran	NULL
(	NULL
Pharmacia	NULL
Fine	NULL
Chemicals	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

5	NULL
ug	NULL
of	NULL
plasmid	NULL
pXGHS5	NULL
,	NULL
a	NULL
mammalian	NULL
expression	NULL
vector	NULL
encoding	NULL
human	NULL
growth	NULL
hormone	NULL
,	NULL
was	NULL
cotrans-	NULL
488	NULL
Roles	NULL
of	NULL
High	NULL
Mobility	NULL
Group	NULL
Protein	NULL
I/Y	NULL
and	NULL
Oct-2	NULL
in	NULL
HLA-DRA	NULL
Transcription	NULL
fected	NULL
with	NULL
reporter	NULL
constructs	NULL
to	NULL
control	NULL
for	NULL
variability	NULL
in	NULL
transfection	NULL
efficiency	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
before	NULL
addition	NULL
of	NULL
medium	NULL
.	NULL

48	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
serum-free	NULL
media	NULL
and	NULL
pelleted	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
300	NULL
pul	NULL
of	NULL
0.25	NULL
M	NULL
Tris	NULL
and	NULL
freeze-thawed	NULL
three	NULL
times	NULL
.	NULL

After	NULL
centrifugation	NULL
in	NULL
a	NULL
microfuge	NULL
to	NULL
remove	NULL
debris	NULL
,	NULL
150	NULL
pl	NULL
of	NULL
the	NULL
cell	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
20	NULL
pl	NULL
10	NULL
mM	NULL
acetyl	NULL
coenzyme	NULL
A	NULL
(	NULL
Pharmacia	NULL
Fine	NULL
Chemicals	NULL
)	NULL
and	NULL
2	NULL
wl	NULL
of	NULL
[	NULL
``	NULL
CJchloramphenicol	NULL
(	NULL
New	NULL
England	NULL
Nuclear	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
(	NULL
49	NULL
mCi/mmol	NULL
,	NULL
0.1	NULL
mCi/ml	NULL
)	NULL
for	NULL
4	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
chloramphenicol	NULL
was	NULL
then	NULL
extracted	NULL
with	NULL
1	NULL
ml	NULL
ethyl	NULL
acetate	NULL
,	NULL
speed	NULL
vacuum	NULL
dried	NULL
,	NULL
and	NULL
spotted	NULL
onto	NULL
TLC	NULL
plates	NULL
.	NULL

After	NULL
the	NULL
solvent	NULL
front	NULL
was	NULL
allowed	NULL
to	NULL
travel	NULL
three-quarters	NULL
of	NULL
the	NULL
length	NULL
of	NULL
the	NULL
plate	NULL
,	NULL
the	NULL
plate	NULL
was	NULL
removed	NULL
from	NULL
the	NULL
chromatog-raphy	NULL
tank	NULL
,	NULL
allowed	NULL
to	NULL
dry	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
.	NULL

For	NULL
quantitation	NULL
of	NULL
CAT	NULL
activity	NULL
,	NULL
appropriate	NULL
slices	NULL
of	NULL
the	NULL
TLC	NULL
plates	NULL
were	NULL
analyzed	NULL
by	NULL
liquid	NULL
scintillation	NULL
counting	NULL
.	NULL

Gel	NULL
Retardation	NULL
Analysis	NULL
.	NULL

-	NULL
Jijoye	NULL
and	NULL
Hela	NULL
whole-cell	NULL
extracts	NULL
for	NULL
gel	NULL
shift	NULL
analysis	NULL
were	NULL
prepared	NULL
using	NULL
a	NULL
modification	NULL
of	NULL
a	NULL
protocol	NULL
(	NULL
45	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
3-5	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
pelleted	NULL
,	NULL
washed	NULL
in	NULL
ice-cold	NULL
PBS	NULL
,	NULL
then	NULL
resuspended	NULL
in	NULL
100	NULL
pul	NULL
of	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
200	NULL
mM	NULL
KCl	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
PMSF	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
NP-40	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
periodic	NULL
agitation	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
cells	NULL
and	NULL
large	NULL
debris	NULL
were	NULL
pelleted	NULL
by	NULL
10-min	NULL
14,000-rpm	NULL
centrifugation	NULL
in	NULL
a	NULL
microfuge	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
the	NULL
super-natant	NULL
,	NULL
containing	NULL
proteins	NULL
solubilized	NULL
from	NULL
both	NULL
the	NULL
nucleus	NULL
and	NULL
the	NULL
cytosol	NULL
in	NULL
the	NULL
extraction	NULL
media	NULL
,	NULL
removed	NULL
,	NULL
aliquoted	NULL
,	NULL
quick-frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

For	NULL
nuclear	NULL
extract	NULL
prep-aration	NULL
,	NULL
500	NULL
ml	NULL
of	NULL
log	NULL
phase	NULL
cells	NULL
was	NULL
pelleted	NULL
at	NULL
2,000	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
cell	NULL
pellet	NULL
was	NULL
washed	NULL
twice	NULL
in	NULL
ice-cold	NULL
PBS	NULL
and	NULL
resuspended	NULL
in	NULL
25	NULL
ml	NULL
nuclear	NULL
isolation	NULL
buffer	NULL
I	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
10	NULL
mM	NULL
KCl	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
;	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
DTT	NULL
)	NULL
.	NULL

0.3	NULL
ml	NULL
of	NULL
ice-cold	NULL
10	NULL
%	NULL
NP-40	NULL
was	NULL
added	NULL
dropwise	NULL
(	NULL
while	NULL
vortexing	NULL
at	NULL
lowest	NULL
setting	NULL
)	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
20	NULL
min	NULL
.	NULL

The	NULL
cell	NULL
lysate	NULL
was	NULL
layered	NULL
onto	NULL
12	NULL
ml	NULL
of	NULL
ice-cold	NULL
nuclear	NULL
isolation	NULL
buffer	NULL
I	NULL
containing	NULL
1.7	NULL
M	NULL
sucrose	NULL
and	NULL
centrifuged	NULL
at	NULL
13,000	NULL
g	NULL
for	NULL
15	NULL
min	NULL
in	NULL
an	NULL
SW27	NULL
rotor	NULL
(	NULL
Beckman	NULL
Instruments	NULL
,	NULL
Inc.	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Purified	NULL
nuclei	NULL
were	NULL
then	NULL
resuspended	NULL
in	NULL
3	NULL
ml	NULL
of	NULL
ice-cold	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
0.42	NULL
M	NULL
NaCl	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
homogenized	NULL
with	NULL
10	NULL
strokes	NULL
of	NULL
a	NULL
Dounce	NULL
homogenizer	NULL
on	NULL
ice	NULL
.	NULL

The	NULL
suspension	NULL
was	NULL
then	NULL
rocked	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
and	NULL
centrifuged	NULL
for	NULL
30	NULL
min	NULL
at	NULL
25,000	NULL
g	NULL
in	NULL
an	NULL
$	NULL
$	NULL
34	NULL
rotor	NULL
(	NULL
Beckman	NULL
Instruments	NULL
)	NULL
.	NULL

The	NULL
superna-tant	NULL
was	NULL
then	NULL
dialyzed	NULL
against	NULL
150	NULL
ml	NULL
of	NULL
transcription	NULL
buffer	NULL
(	NULL
-+NTPs	NULL
)	NULL
:	NULL
12	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
12	NULL
%	NULL
glycerol	NULL
,	NULL
0.3	NULL
mM	NULL
DTT	NULL
,	NULL
0.12	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
60	NULL
mM	NULL
KCI	NULL
for	NULL
5	NULL
h.	NULL
MgCl	NULL
;	NULL
was	NULL
omitted	NULL
from	NULL
those	NULL
preparations	NULL
to	NULL
be	NULL
used	NULL
for	NULL
gel-retardation	NULL
assay	NULL
,	NULL
as	NULL
MgCl	NULL
]	NULL
;	NULL
has	NULL
been	NULL
found	NULL
to	NULL
inhibit	NULL
gel	NULL
retardation	NULL
.	NULL

For	NULL
gel-shift	NULL
analysis	NULL
,	NULL
*P	NULL
end-labeled	NULL
probes	NULL
(	NULL
5,000-15,000	NULL
cpm	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
a	NULL
10-pl	NULL
vol	NULL
with	NULL
pure	NULL
recombinant	NULL
proteins	NULL
or	NULL
extracts	NULL
on	NULL
ice	NULL
for	NULL
25	NULL
min	NULL
.	NULL

Binding	NULL
condition	NULL
for	NULL
recombinant	NULL
HMG	NULL
I/Y	NULL
was	NULL
10	NULL
mM	NULL
Tris.Cl	NULL
(	NULL
pH	NULL
7.6	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
NaC	NULL
)	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
100	NULL
ng	NULL
of	NULL
poly	NULL
(	NULL
dG.dC	NULL
)	NULL
.	NULL

Poly	NULL
(	NULL
dG-dC	NULL
)	NULL
was	NULL
always	NULL
used	NULL
since	NULL
HMG	NULL
I/Y	NULL
binding	NULL
is	NULL
sensitive	NULL
to	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

Octamer	NULL
protein-binding	NULL
reactions	NULL
were	NULL
in	NULL
20	NULL
mM	NULL
Hepes	NULL
pH	NULL
7.9	NULL
,	NULL
2	NULL
mM	NULL
DTT	NULL
,	NULL
8	NULL
%	NULL
glycerol	NULL
,	NULL
40	NULL
mM	NULL
KCl	NULL
,	NULL
0.01	NULL
%	NULL
NP-40	NULL
,	NULL
and	NULL
100-500	NULL
ng	NULL
of	NULL
poly	NULL
(	NULL
dG.dC	NULL
)	NULL
or	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

The	NULL
total	NULL
amounts	NULL
of	NULL
protein	NULL
in	NULL
reactions	NULL
containing	NULL
exogenous	NULL
HMG	NULL
I	NULL
were	NULL
kept	NULL
constant	NULL
by	NULL
using	NULL
BSA	NULL
or	NULL
recombinant	NULL
IFN-y	NULL
.	NULL

Antibody	NULL
to	NULL
HMG	NULL
I/Y	NULL
was	NULL
generated	NULL
as	NULL
described	NULL
(	NULL
43	NULL
)	NULL
and	NULL
an	NULL
anti-	NULL
@	NULL
gal	NULL
antibody	NULL
was	NULL
purchased	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
1	NULL
pl	NULL
antibody	NULL
was	NULL
used	NULL
per	NULL
reaction	NULL
.	NULL

Reactions	NULL
were	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
in	NULL
a	NULL
nondenaturating	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
0.5	NULL
x	NULL
Tris-buffered	NULL
EDTA	NULL
.	NULL

Bands	NULL
were	NULL
quantitated	NULL
by	NULL
densitometry	NULL
.	NULL

The	NULL
Y	NULL
+	NULL
OCT	NULL
probe	NULL
has	NULL
the	NULL
sequence	NULL
:	NULL
489	NULL
Abdulkadir	NULL
et	NULL
al	NULL
.	NULL

5TCTCAAAATATTTTTCTGATTGGCCAAAGAGTAATT-GATTTGCATTTTAAT3	NULL
,	NULL
the	NULL
DRA-OCT	NULL
oligo	NULL
:	NULL
5-AGAGTAATTGATTTGCATTTTAATGG-3	NULL
,	NULL
and	NULL
the	NULL
DRA-IS	NULL
oligo	NULL
:	NULL
SATCTCAAAATATTTTTCTGATTGGCCA-3	NULL
'	NULL
.	NULL

DNaseI	NULL
Footprint	NULL
Analysis	NULL
.	NULL

-	NULL
Both	NULL
strands	NULL
of	NULL
the	NULL
DRA	NULL
proximal	NULL
promoter	NULL
were	NULL
subjected	NULL
to	NULL
DNasel	NULL
footprint	NULL
analysis	NULL
using	NULL
the	NULL
plasmid	NULL
pBSDRA300	NULL
which	NULL
contains	NULL
nucleotides	NULL
-268	NULL
to	NULL
+29	NULL
of	NULL
the	NULL
DRA	NULL
gene	NULL
inserted	NULL
into	NULL
the	NULL
pBluescript	NULL
KS	NULL
vector	NULL
between	NULL
the	NULL
HindIII	NULL
and	NULL
EcoRI	NULL
restriction	NULL
sites	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Strand-specific	NULL
labeling	NULL
was	NULL
achieved	NULL
by	NULL
labeling	NULL
after	NULL
digestion	NULL
with	NULL
either	NULL
HindIII	NULL
or	NULL
EcoRI	NULL
,	NULL
followed	NULL
by	NULL
complete	NULL
digestion	NULL
with	NULL
the	NULL
other	NULL
restriction	NULL
enzyme	NULL
.	NULL

The	NULL
radiolabeled	NULL
DRA	NULL
proximal	NULL
promoter	NULL
was	NULL
then	NULL
purified	NULL
by	NULL
elution	NULL
after	NULL
gel	NULL
electrophoresis	NULL
and	NULL
the	NULL
specific	NULL
activity	NULL
of	NULL
the	NULL
fragment	NULL
determined	NULL
by	NULL
scintillation	NULL
counting	NULL
.	NULL

Footprinting	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
50-pl	NULL
binding	NULL
reactions	NULL
containing	NULL
10,000	NULL
cpm	NULL
of	NULL
purified	NULL
probe	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
recombinant	NULL
HMG	NULL
I	NULL
protein	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
25	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
BSA	NULL
,	NULL
0.01	NULL
%	NULL
NP-40	NULL
,	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
dG/dC	NULL
as	NULL
a	NULL
nonspecific	NULL
competitor	NULL
DNA	NULL
.	NULL

DNA	NULL
was	NULL
fragmented	NULL
for	NULL
1	NULL
min	NULL
in	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
4	NULL
mM	NULL
MgC	NULL
]	NULL
;	NULL
using	NULL
0.2	NULL
U	NULL
of	NULL
DNasel	NULL
.	NULL

After	NULL
1	NULL
min	NULL
,	NULL
the	NULL
reaction	NULL
was	NULL
terminated	NULL
with	NULL
a	NULL
solution	NULL
containing	NULL
2	NULL
%	NULL
SDS	NULL
,	NULL
200	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
salmon	NULL
sperm	NULL
DNA	NULL
.	NULL

After	NULL
phenol-chloroform	NULL
extraction	NULL
,	NULL
reaction	NULL
mixtures	NULL
were	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
on	NULL
an	NULL
8	NULL
%	NULL
polyacrylamide	NULL
sequencing	NULL
gel	NULL
containing	NULL
8	NULL
M	NULL
urea	NULL
.	NULL

A	NULL
G	NULL
+	NULL
A	NULL
sequencing	NULL
ladder	NULL
was	NULL
also	NULL
added	NULL
for	NULL
orientation	NULL
after	NULL
developing	NULL
the	NULL
autoradiograph	NULL
.	NULL

In	NULL
Vitro	NULL
Transcription/	NULL
Translation	NULL
.	NULL

-	NULL
In	NULL
vitro	NULL
translated	NULL
Oct-1	NULL
protein	NULL
was	NULL
made	NULL
from	NULL
the	NULL
pBSOct-1+	NULL
plasmid	NULL
(	NULL
W.	NULL
Herr	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
)	NULL
using	NULL
the	NULL
TNT	NULL
coupled	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
system	NULL
(	NULL
Promega	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Results	NULL
Differential	NULL
Requirement	NULL
of	NULL
the	NULL
Octamer-binding	NULL
Protein	NULL
Oct-2	NULL
for	NULL
the	NULL
B	NULL
Cell-specific	NULL
Expression	NULL
of	NULL
the	NULL
HLA-DR	NULL
A	NULL
and	NULL
HL	NULL
A-DQB	NULL
Genes	NULL
.	NULL

-	NULL
Among	NULL
the	NULL
human	NULL
class	NULL
II	NULL
MHC	NULL
genes	NULL
,	NULL
only	NULL
the	NULL
HLA-DRA	NULL
and	NULL
HLA-DQB	NULL
promoters	NULL
have	NULL
been	NULL
found	NULL
to	NULL
contain	NULL
an	NULL
octamer-binding	NULL
site	NULL
(	NULL
36	NULL
,	NULL
38	NULL
;	NULL
our	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

In	NULL
the	NULL
DRA	NULL
promoter	NULL
the	NULL
octamer	NULL
element	NULL
is	NULL
located	NULL
between	NULL
-52	NULL
and	NULL
-45	NULL
bp	NULL
upstream	NULL
from	NULL
the	NULL
start	NULL
site	NULL
of	NULL
transcription	NULL
,	NULL
while	NULL
the	NULL
octamer	NULL
element	NULL
in	NULL
the	NULL
DQB	NULL
promoter	NULL
is	NULL
located	NULL
between	NULL
-611	NULL
and	NULL
-604	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
A4	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
established	NULL
that	NULL
the	NULL
octamer	NULL
motif	NULL
in	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
binds	NULL
both	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
and	NULL
mutations	NULL
that	NULL
abolish	NULL
in	NULL
vitro	NULL
binding	NULL
adversely	NULL
affect	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
16	NULL
,	NULL
42	NULL
,	NULL
46	NULL
;	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Since	NULL
both	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
proteins	NULL
are	NULL
expressed	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
we	NULL
were	NULL
interested	NULL
in	NULL
determining	NULL
whether	NULL
one	NULL
or	NULL
both	NULL
of	NULL
these	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
HLA-DRA	NULL
expression	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
cotransfected	NULL
expression	NULL
vectors	NULL
that	NULL
direct	NULL
the	NULL
synthesis	NULL
of	NULL
either	NULL
Oct-1	NULL
or	NULL
Oct-2A	NULL
antisense	NULL
RNA	NULL
with	NULL
the	NULL
HLA-DRA	NULL
reporter	NULL
construct	NULL
.	NULL

While	NULL
the	NULL
vector	NULL
encoding	NULL
antisense	NULL
Oct-1	NULL
RNA	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
either	NULL
DRA	NULL
or	NULL
DQB	NULL
promoter	NULL
ac	NULL
A	NULL
B	NULL
RAJI	NULL
Cells	NULL
Dra	NULL
Tem	NULL
w	NULL
W	NULL
x	NULL
1	NULL
v	NULL
lOCTlTATAi	NULL
~160	NULL
+1	NULL
DRA3OOCAT	NULL
DQB2500CAT	NULL
DaB	NULL
[	NULL
OCT-Igow	NULL
morcy	NULL
-i-	NULL
&	NULL
¢	NULL
a	NULL
&	NULL
2	NULL
&	NULL
£	NULL
+600	NULL
A	NULL
+1	NULL
x	NULL
Ay	NULL
6	NULL
(	NULL
SJ	NULL
of	NULL
}	NULL
a	NULL
?	NULL

o	NULL
<	NULL
5	NULL
}	NULL
foo	NULL
a	NULL
?	NULL

QQ	NULL
‘	NULL
_-	NULL
&	NULL
&	NULL
Ku	NULL
-_	NULL
Fu	NULL
Fa	NULL
#	NULL
6	NULL
@	NULL
%	NULL
e	NULL
6	NULL
$	NULL
&	NULL
#	NULL
&	NULL
%	NULL
*	NULL
%	NULL
&	NULL
4	NULL
%	NULL
*	NULL
6	NULL
eo	NULL
oe	NULL
o	NULL
0	NULL
eo	NULL
8	NULL
8	NULL
®	NULL
A	NULL
CONTROL	NULL
{	NULL
ll	NULL
ADR	NULL
HLA-DQ	NULL
HLA-DP	NULL
Antisense	NULL
BZLF	NULL
1	NULL
L	NULL
‘	NULL
a	NULL
D	NULL
PA	NULL
OCT2	NULL
A	NULL
A	NULL
s	NULL
SFA	NULL
ad	NULL
a	NULL
a	NULL
ad	NULL
s	NULL
l	NULL
3	NULL
Cadudistloce®	NULL
Antisense	NULL
5	NULL
q	NULL
``	NULL
W	NULL
C	NULL
Oct	NULL
1	NULL
L	NULL
‘	NULL
‘	NULL
{	NULL
a	NULL
RAJ	NULL
:	NULL
Bob	NULL
Bob	NULL
44	NULL
Antisense	NULL
®	NULL
sons	NULL
OCT	NULL
1	NULL
Oct	NULL
2	NULL
ii	NULL
‘	NULL
‘	NULL
_	NULL
i	NULL
Oct	NULL
2	NULL
s	NULL
m	NULL
B	NULL
Antisense	NULL
**	NULL
``	NULL
kl	NULL
_|	NULL
LA	NULL
|	NULL
Lk	NULL
|	NULL
sak	NULL
0	NULL
;	NULL
SORT	NULL
HIGH	NULL
f	NULL
?	NULL

SORT	NULL
LOW	NULL
FLUORESCENCE	NULL
INTENSITY	NULL
Figure	NULL
1	NULL
.	NULL

-	NULL
Antisense	NULL
Oct-2	NULL
RNA	NULL
blocks	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
HLA-DRA	NULL
,	NULL
but	NULL
not	NULL
the	NULL
-DQB	NULL
promoter	NULL
in	NULL
Raji	NULL
cells	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Diagram	NULL
showing	NULL
the	NULL
location	NULL
of	NULL
octamer-binding	NULL
sites	NULL
within	NULL
the	NULL
human	NULL
class	NULL
II	NULL
MHC	NULL
gene	NULL
promoters	NULL
:	NULL
HLA-DRA	NULL
(	NULL
-52	NULL
to	NULL
-45	NULL
bp	NULL
)	NULL
and	NULL
HLA-DQB	NULL
(	NULL
~611	NULL
to	NULL
-604	NULL
bp	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Effect	NULL
of	NULL
expression	NULL
of	NULL
antisense	NULL
Oct-2	NULL
RNA	NULL
on	NULL
HLA-DRA	NULL
and	NULL
DQB	NULL
promoter	NULL
activity	NULL
as	NULL
assessed	NULL
by	NULL
CAT	NULL
assay	NULL
.	NULL

Raji	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
reporter	NULL
constructs	NULL
(	NULL
pHGCAT	NULL
is	NULL
a	NULL
promoterless	NULL
CAT	NULL
plasmid	NULL
)	NULL
.	NULL

Lanes	NULL
marked	NULL
-	NULL
were	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
only	NULL
the	NULL
reporter	NULL
construct	NULL
.	NULL

In	NULL
the	NULL
remaining	NULL
lanes	NULL
the	NULL
cells	NULL
also	NULL
received	NULL
the	NULL
indicated	NULL
antisense	NULL
vector	NULL
.	NULL

a.s.	NULL
BZLF1	NULL
directs	NULL
the	NULL
expression	NULL
of	NULL
an	NULL
antisense	NULL
BZLF1	NULL
RNA	NULL
{	NULL
the	NULL
immediate	NULL
early	NULL
response	NULL
transcription	NULL
factor	NULL
Zebra	NULL
,	NULL
involved	NULL
in	NULL
the	NULL
latent/lytic	NULL
transition	NULL
of	NULL
EBV	NULL
;	NULL
a.s.	NULL
Oct1	NULL
directs	NULL
the	NULL
expression	NULL
of	NULL
antisense	NULL
Oct1	NULL
RNA	NULL
;	NULL
a.s.	NULL
Oct2	NULL
directs	NULL
the	NULL
expression	NULL
of	NULL
antisense	NULL
Oct2¥A	NULL
RNA	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
effect	NULL
of	NULL
antisense	NULL
Oct1	NULL
or	NULL
Oct2	NULL
RNA	NULL
on	NULL
cell-surface	NULL
expression	NULL
of	NULL
endogenously	NULL
encoded	NULL
MHC	NULL
class	NULL
II	NULL
molecules	NULL
.	NULL

Raji	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
vectors	NULL
described	NULL
in	NULL
B	NULL
and	NULL
cell-surface	NULL
expression	NULL
of	NULL
the	NULL
HLA-DR	NULL
,	NULL
-DQ	NULL
,	NULL
and	NULL
-DP	NULL
molecules	NULL
was	NULL
assessed	NULL
by	NULL
flow-cytometric	NULL
analysis	NULL
using	NULL
isotype-specific	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
subpanel	NULL
A	NULL
)	NULL
.	NULL

Synthesis	NULL
of	NULL
antisense	NULL
Oct2	NULL
RNA	NULL
resulted	NULL
in	NULL
the	NULL
specific	NULL
down-regulation	NULL
of	NULL
HLA-DR	NULL
expression	NULL
.	NULL

The	NULL
subpopulation	NULL
of	NULL
cells	NULL
expressing	NULL
reduced	NULL
levels	NULL
of	NULL
HLA-DR	NULL
was	NULL
purified	NULL
by	NULL
cell-sorting	NULL
(	NULL
subpanel	NULL
B	NULL
)	NULL
.	NULL

The	NULL
same	NULL
cells	NULL
that	NULL
expressed	NULL
reduced	NULL
HLA-DR	NULL
,	NULL
expressed	NULL
wild-type	NULL
levels	NULL
of	NULL
HLA-DQ	NULL
and	NULL
-DP	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Raji	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
control	NULL
antisense	NULL
vector	NULL
pRSV2.Z	NULL
or	NULL
the	NULL
antisense	NULL
Oct2	NULL
expression	NULL
vector	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
the	NULL
antisense	NULL
Oct2	NULL
expression	NULL
vector	NULL
were	NULL
then	NULL
sorted	NULL
into	NULL
HLA-DR	NULL
high	NULL
and	NULL
low	NULL
populations	NULL
by	NULL
flow	NULL
cytometry	NULL
,	NULL
based	NULL
upon	NULL
cell-surface	NULL
HLA-DR	NULL
expression	NULL
levels	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
these	NULL
cells	NULL
and	NULL
assessed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
octamer-binding	NULL
proteins	NULL
by	NULL
EMSA	NULL
.	NULL

The	NULL
lane	NULL
marked	NULL
Control	NULL
contains	NULL
extract	NULL
from	NULL
unsorted	NULL
,	NULL
pa.	NULL
Oct2-transfected	NULL
Raji	NULL
cells	NULL
.	NULL

Cells	NULL
expressing	NULL
decreased	NULL
levels	NULL
of	NULL
cell-surface	NULL
HLA-DR	NULL
(	NULL
lanes	NULL
marked	NULL
Low	NULL
)	NULL
show	NULL
no	NULL
detectable	NULL
levels	NULL
of	NULL
Oct2	NULL
.	NULL

tivity	NULL
(	NULL
in	NULL
the	NULL
B	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
Raji	NULL
)	NULL
,	NULL
the	NULL
vector	NULL
encoding	NULL
antisense	NULL
Oct-2A	NULL
RNA	NULL
strongly	NULL
down-regulated	NULL
expression	NULL
of	NULL
the	NULL
DRA	NULL
(	NULL
but	NULL
not	NULL
the	NULL
DQB	NULL
)	NULL
promoter	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
.	NULL

To	NULL
further	NULL
assess	NULL
the	NULL
significance	NULL
of	NULL
the	NULL
octamer-binding	NULL
proteins	NULL
on	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
class	NULL
II	NULL
MHC	NULL
genes	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
effect	NULL
of	NULL
antisense	NULL
Oct-1	NULL
and	NULL
Oct-2A	NULL
RNA	NULL
production	NULL
on	NULL
the	NULL
cell-surface	NULL
expression	NULL
of	NULL
the	NULL
endogenous	NULL
class	NULL
II	NULL
molecules	NULL
in	NULL
the	NULL
B	NULL
cell	NULL
line	NULL
Raji	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
C	NULL
)	NULL
.	NULL

Raji	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
either	NULL
the	NULL
antisense	NULL
Oct-1	NULL
or	NULL
Oct2A	NULL
expression	NULL
vector	NULL
and	NULL
then	NULL
analyzed	NULL
for	NULL
surface	NULL
class	NULL
II	NULL
antigen	NULL
expression	NULL
by	NULL
flow	NULL
cytometric	NULL
analysis	NULL
using	NULL
isotype-specific	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
note	NULL
that	NULL
cell-surface	NULL
expression	NULL
of	NULL
any	NULL
of	NULL
the	NULL
class	NULL
II	NULL
isotypes	NULL
requires	NULL
transcription	NULL
and	NULL
translation	NULL
of	NULL
both	NULL
the	NULL
&	NULL
and	NULL
3	NULL
chain	NULL
genes	NULL
.	NULL

Therefore	NULL
,	NULL
a	NULL
reduction	NULL
in	NULL
expression	NULL
of	NULL
either	NULL
an	NULL
&	NULL
or	NULL
3	NULL
chain	NULL
gene	NULL
at	NULL
a	NULL
particular	NULL
locus	NULL
will	NULL
result	NULL
in	NULL
decreased	NULL
cell-surface	NULL
expression	NULL
of	NULL
that	NULL
particular	NULL
isotype	NULL
.	NULL

Significantly	NULL
,	NULL
Raji	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
antisense	NULL
Oct-2A	NULL
expression	NULL
vector	NULL
exhibit	NULL
a	NULL
specific	NULL
down-modulation	NULL
of	NULL
HLA-DR	NULL
antigen	NULL
expression	NULL
in	NULL
a	NULL
subpopulation	NULL
of	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
C	NULL
,	NULL
subpanel	NULL
A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
vectors	NULL
encoding	NULL
antisense	NULL
Oct-1	NULL
and	NULL
the	NULL
control	NULL
antisense	NULL
Zebra	NULL
RNA	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
cell-surface	NULL
expression	NULL
of	NULL
any	NULL
of	NULL
the	NULL
class	NULL
II	NULL
isotypes	NULL
.	NULL

To	NULL
further	NULL
characterize	NULL
this	NULL
phenomenon	NULL
,	NULL
the	NULL
subpopulation	NULL
of	NULL
Raji	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
antisense	NULL
Oct-2A	NULL
expression	NULL
vector	NULL
(	NULL
designated	NULL
:	NULL
HLA-DRA	NULL
sort	NULL
low	NULL
)	NULL
were	NULL
purified	NULL
by	NULL
cell	NULL
sorting	NULL
and	NULL
shown	NULL
to	NULL
express	NULL
wild-type	NULL
levels	NULL
490	NULL
Roles	NULL
of	NULL
High	NULL
Mobility	NULL
Group	NULL
Protein	NULL
I/Y	NULL
and	NULL
Oct-2	NULL
in	NULL
HLA-DRA	NULL
Transcription	NULL
of	NULL
HLA-DQ	NULL
and	NULL
-DP	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
C	NULL
,	NULL
subpanel	NULL
B	NULL
)	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
then	NULL
prepared	NULL
from	NULL
the	NULL
sorted	NULL
populations	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
antisense	NULL
Oct-2A	NULL
expression	NULL
vector	NULL
and	NULL
analyzed	NULL
by	NULL
gel	NULL
mobility	NULL
shift	NULL
assay	NULL
for	NULL
expression	NULL
of	NULL
the	NULL
octamer-binding	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
D	NULL
)	NULL
.	NULL

The	NULL
sorted	NULL
subpopulation	NULL
of	NULL
Raji	NULL
cells	NULL
expressing	NULL
markedly	NULL
decreased	NULL
levels	NULL
of	NULL
cell	NULL
surface	NULL
HLA-DR	NULL
molecules	NULL
showed	NULL
reduced	NULL
levels	NULL
of	NULL
Oct-2	NULL
protein	NULL
(	NULL
lanes	NULL
marked	NULL
Low	NULL
)	NULL
,	NULL
while	NULL
the	NULL
subpopulation	NULL
of	NULL
antisense	NULL
Oct-2A	NULL
expression	NULL
vector	NULL
transfected	NULL
cells	NULL
that	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
surface	NULL
HLA-DR	NULL
retain	NULL
normal	NULL
levels	NULL
of	NULL
Oct-2	NULL
protein	NULL
(	NULL
lanes	NULL
marked	NULL
High	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
there	NULL
is	NULL
a	NULL
correlation	NULL
between	NULL
reduced	NULL
cell-surface	NULL
expression	NULL
of	NULL
HLA-DR	NULL
molecules	NULL
and	NULL
reduced	NULL
A	NULL
QCT	NULL
-_	NULL
L	NULL
--	NULL
--	NULL
-ATTTGCAT	NULL
—	NULL
[	NULL
{	NULL
._____j	NULL
L_	NULL
,	NULL
o	NULL
--	NULL
--	NULL
arggecat	NULL
--	NULL
-IT	NULL
--	NULL
-3	NULL
e	NULL
cF	NULL
B	NULL
_	NULL
CELLS	NULL
e	NULL
amounts	NULL
of	NULL
Oct-2	NULL
protein	NULL
.	NULL

The	NULL
subpopulation	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
antisense	NULL
Oct-2A	NULL
expression	NULL
vector	NULL
that	NULL
express	NULL
wild-type	NULL
levels	NULL
of	NULL
HLA-DR	NULL
presumably	NULL
did	NULL
not	NULL
incorporate	NULL
the	NULL
expression	NULL
vector	NULL
.	NULL

The	NULL
Octamer-binding	NULL
Protein	NULL
Oct-2A	NULL
Is	NULL
Not	NULL
Required	NULL
for	NULL
IFN-y	NULL
Induction	NULL
of	NULL
the	NULL
HLA-DR	NULL
A	NULL
Gene	NULL
.	NULL

To	NULL
further	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
the	NULL
octamer-binding	NULL
site	NULL
in	NULL
IFN-y	NULL
induction	NULL
of	NULL
the	NULL
HLA-DR	NULL
promoter	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
mutations	NULL
in	NULL
this	NULL
site	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
DRA300CAT	NULL
reporter	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
in	NULL
Hela	NULL
cells	NULL
We	NULL
substituted	NULL
the	NULL
TT	NULL
bases	NULL
for	NULL
GG	NULL
in	NULL
the	NULL
octamer	NULL
element	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
.	NULL

This	NULL
mutation	NULL
drastically	NULL
reduced	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
reporter	NULL
HELA	NULL
CELLS	NULL
I	NULL
A	NULL
A	NULL
6	NULL
|	NULL
p	NULL
>	NULL
C	NULL
d	NULL
?	NULL

an	NULL
y	NULL
§	NULL
$	NULL
9	NULL
$	NULL
9	NULL
&	NULL
}	NULL
y	NULL
A	NULL
A	NULL
é	NULL
;	NULL
OQ	NULL
QQ	NULL
?	NULL

VS	NULL
;	NULL
*	NULL
T	NULL
t	NULL
?	NULL

?	NULL

Figure	NULL
2	NULL
.	NULL

The	NULL
octamer-binding	NULL
site	NULL
is	NULL
required	NULL
for	NULL
HLA-DRA	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
for	NULL
its	NULL
IFN-y	NULL
induction	NULL
in	NULL
Hela	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Diagram	NULL
showing	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
octamer	NULL
sequence	NULL
in	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
.	NULL

Base	NULL
substitutions	NULL
were	NULL
introduced	NULL
using	NULL
the	NULL
PCR	NULL
.	NULL

(	NULL
B	NULL
)	NULL
A	NULL
representative	NULL
CAT	NULL
assay	NULL
showing	NULL
the	NULL
effect	NULL
of	NULL
octamer	NULL
site	NULL
mutations	NULL
on	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
mutant	NULL
and	NULL
wild-type	NULL
DRA300CAT	NULL
reporter	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
the	NULL
class	NULL
II-positive	NULL
B	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
Jijoye	NULL
and	NULL
cell	NULL
extracts	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

pCAT-basic	NULL
(	NULL
Promega	NULL
)	NULL
is	NULL
a	NULL
promoterless	NULL
CAT	NULL
construct	NULL
.	NULL

AB2CAT	NULL
contains	NULL
the	NULL
mutation	NULL
in	NULL
the	NULL
octamer	NULL
motif	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
effects	NULL
E	NULL
HeLa	NULL
+	NULL
IFN	NULL
of	NULL
octamer	NULL
site	NULL
mutations	NULL
on	NULL
IFN-y	NULL
induction	NULL
in	NULL
Hela	NULL
I	NULL
cells	NULL
.	NULL

(	NULL
-	NULL
)	NULL
refers	NULL
to	NULL
extracts	NULL
from	NULL
uninduced	NULL
cells	NULL
,	NULL
(	NULL
+	NULL
)	NULL
refers	NULL
.	NULL

0	NULL
4	NULL
0	NULL
4	NULL
00	NULL
>	NULL
-	NULL
_-	NULL
to	NULL
IFN-y-induced	NULL
cells	NULL
.	NULL

A	NULL
representative	NULL
CAT	NULL
assay	NULL
is	NULL
c-BGal	NULL
D	NULL
Hela	NULL
«	NULL
IFN	NULL
®	NULL
4	NULL
oo	NULL
o	NULL
@	NULL
-	NULL
£	NULL
€	NULL
8	NULL
*	NULL
Oct	NULL
»	NULL
‘	NULL
|	NULL
ladind	NULL
HMG	NULL
I	NULL
i=	NULL
Hela	NULL
«	NULL
TFN	NULL
al	NULL
Fog	NULL
'd§	NULL
!	NULL

“	NULL
‘	NULL
1	NULL
‘	NULL
s	NULL
100X	NULL
Competiton	NULL
:	NULL
HMG	NULL
|	NULL
102	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
Octamer	NULL
i=	NULL
8	NULL
9	NULL
10	NULL
Octamer	NULL
»	NULL
491	NULL
Abdulkadit	NULL
et	NULL
al	NULL
.	NULL

Wie	NULL
«	NULL
--	NULL
«	NULL
ar	NULL
apaie	NULL
shown	NULL
.	NULL

(	NULL
D	NULL
)	NULL
IFN-y	NULL
treatment	NULL
of	NULL
HeLa	NULL
cells	NULL
does	NULL
not	NULL
induce	NULL
detectable	NULL
levels	NULL
of	NULL
Oct-2	NULL
protein	NULL
.	NULL

A	NULL
gel-shift	NULL
assay	NULL
showing	NULL
octamer-binding	NULL
proteins	NULL
in	NULL
extracts	NULL
from	NULL
Hela	NULL
cells	NULL
induced	NULL
(	NULL
+IFN	NULL
)	NULL
or	NULL
uninduced	NULL
(	NULL
-IFN	NULL
)	NULL
with	NULL
IFN-y	NULL
.	NULL

100-fold	NULL
excess	NULL
of	NULL
the	NULL
following	NULL
competitors	NULL
(	NULL
all	NULL
from	NULL
Promega	NULL
)	NULL
were	NULL
used	NULL
:	NULL
OCT	NULL
(	NULL
the	NULL
consensus	NULL
octamer	NULL
)	NULL
,	NULL
API	NULL
(	NULL
the	NULL
consensus	NULL
AP1	NULL
oligo	NULL
)	NULL
,	NULL
AP3	NULL
(	NULL
the	NULL
consensus	NULL
AP3-binding	NULL
site	NULL
from	NULL
the	NULL
SV40	NULL
enhancer	NULL
)	NULL
,	NULL
and	NULL
CTF	NULL
(	NULL
the	NULL
consensus	NULL
CTR/NF1-binding	NULL
site	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
contains	NULL
free	NULL
probe	NULL
.	NULL

The	NULL
specific	NULL
band	NULL
corresponding	NULL
to	NULL
Oct-1	NULL
is	NULL
arrowed	NULL
.	NULL

The	NULL
fast	NULL
migrating	NULL
HMG	NULL
I/Y-containing	NULL
complex	NULL
(	NULL
lanes	NULL
7-10	NULL
)	NULL
is	NULL
indicated	NULL
.	NULL

The	NULL
unlabeled	NULL
arrow	NULL
indicates	NULL
a	NULL
band	NULL
seen	NULL
in	NULL
some	NULL
preparations	NULL
of	NULL
induced	NULL
HeLa	NULL
cells	NULL
,	NULL
which	NULL
,	NULL
however	NULL
,	NULL
is	NULL
not	NULL
specific	NULL
.	NULL

(	NULL
E	NULL
)	NULL
EMSA	NULL
with	NULL
extracts	NULL
from	NULL
induced	NULL
HeLa	NULL
cells	NULL
and	NULL
the	NULL
DRA	NULL
octamer	NULL
.	NULL

Antibody	NULL
against	NULL
HMG	NULL
I/Y	NULL
(	NULL
c-HMG	NULL
1	NULL
)	NULL
inhibits	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
fast-migrating	NULL
complex	NULL
labeled	NULL
as	NULL
HMG	NULL
I/	NULL
Y	NULL
,	NULL
while	NULL
the	NULL
control	NULL
antibody	NULL
against	NULL
A-galactosidase	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
x-BGal	NULL
)	NULL
.	NULL

Non-coding	NULL
Strand	NULL
Coding	NULL
Strand	NULL
B	NULL
TCAGATTGGGGTTAAAGAGTCTGCCGTGATTGACTAACAGTCTTAAATACTTGATTTGTTGTTGTTGTT	NULL
-260	NULL
~~	NULL
--	NULL
E	NULL
Z	NULL
box	NULL
GTCCTGTTTGTTTAAGAAACTTTACTTCTTTATCCAATGAACGGAGTATCTTGTGTCCTGGACCCTTTG	NULL
~192	NULL
X	NULL
box	NULL
Y	NULL
box	NULL
WCMC	NULL
(	NULL
ICTl	NULL
“	NULL
CCCCTAGCAACAGATQJGTCAECMAATAT	NULL
'	NULL
I	NULL
TTTCTGATTGGCCAAAGAGTA	NULL
~120	NULL
D	NULL
Octamer	NULL
T.	NULL
ATA	NULL
box	NULL
ATTGATTTGCATTTTAATGGTCAGACTCTATTACACCCCACATTCTCTTTTCTTITTATTCTTGTCTGT	NULL
C	NULL
B	NULL
A	NULL
gene	NULL
in	NULL
the	NULL
B	NULL
cell	NULL
line	NULL
Jijoye	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
same	NULL
mutations	NULL
in	NULL
the	NULL
octamer-binding	NULL
site	NULL
had	NULL
only	NULL
a	NULL
slight	NULL
effect	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
by	NULL
IFN-y	NULL
in	NULL
Hela	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
)	NULL
.	NULL

While	NULL
the	NULL
octamer	NULL
mutation	NULL
almost	NULL
completely	NULL
abolished	NULL
HLA-DRA	NULL
promoter-driven	NULL
CAT	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
it	NULL
reduced	NULL
CAT	NULL
activity	NULL
in	NULL
Hela	NULL
cells	NULL
to	NULL
between	NULL
70	NULL
and	NULL
80	NULL
%	NULL
of	NULL
wild	NULL
type	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
B	NULL
and	NULL
C	NULL
;	NULL
see	NULL
also	NULL
Fig	NULL
.	NULL

4	NULL
C	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
are	NULL
in	NULL
general	NULL
agreement	NULL
with	NULL
earlier	NULL
reports	NULL
that	NULL
DRA	NULL
reporter	NULL
constructs	NULL
containing	NULL
mutations	NULL
in	NULL
the	NULL
octamer	NULL
element	NULL
have	NULL
impaired	NULL
activities	NULL
in	NULL
B	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
HeLa	NULL
cells	NULL
induced	NULL
with	NULL
IFN-y	NULL
(	NULL
16	NULL
,	NULL
42	NULL
)	NULL
.	NULL

Hela	NULL
cells	NULL
do	NULL
not	NULL
normally	NULL
express	NULL
Oct-2	NULL
protein	NULL
(	NULL
46-48	NULL
)	NULL
.	NULL

We	NULL
,	NULL
however	NULL
,	NULL
wanted	NULL
to	NULL
investigate	NULL
the	NULL
possibility	NULL
that	NULL
Oct-2	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
IFN-y-mediated	NULL
induction	NULL
of	NULL
HLA-DRA	NULL
gene	NULL
expression	NULL
in	NULL
Hela	NULL
cells	NULL
.	NULL

We	NULL
therefore	NULL
assayed	NULL
for	NULL
de	NULL
novo	NULL
Oct-2	NULL
protein	NULL
synthesis	NULL
in	NULL
IFN-y-treated	NULL
Hela	NULL
cells	NULL
by	NULL
gel-shift	NULL
analysis	NULL
using	NULL
the	NULL
DRA-octamer	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
D	NULL
,	NULL
we	NULL
found	NULL
no	NULL
evidence	NULL
of	NULL
de	NULL
novo	NULL
Oct-2	NULL
synthesis	NULL
in	NULL
Hela	NULL
cells	NULL
induced	NULL
with	NULL
IFN-y	NULL
.	NULL

This	NULL
observation	NULL
strongly	NULL
supports	NULL
the	NULL
notion	NULL
that	NULL
induction	NULL
of	NULL
the	NULL
DRA	NULL
Figure	NULL
3	NULL
.	NULL

-	NULL
Identification	NULL
of	NULL
HMG	NULL
I/Y¥-binding	NULL
sites	NULL
in	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
.	NULL

(	NULL
A	NULL
)	NULL
In	NULL
vitro	NULL
DNase	NULL
I	NULL
footprint	NULL
analysis	NULL
of	NULL
regions	NULL
of	NULL
the	NULL
HLA-DRA	NULL
proximal	NULL
promoter	NULL
that	NULL
are	NULL
protected	NULL
by	NULL
binding	NULL
of	NULL
recombinant	NULL
HMG	NULL
I/¥	NULL
.	NULL

The	NULL
noncoding	NULL
strand	NULL
is	NULL
end-labeled	NULL
in	NULL
subpanel	NULL
A	NULL
and	NULL
the	NULL
coding	NULL
strand	NULL
in	NULL
subpanel	NULL
B	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
7	NULL
are	NULL
Maxam-Gilbert	NULL
G	NULL
+	NULL
A	NULL
sequencing	NULL
ladders	NULL
.	NULL

Lanes	NULL
2	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
and	NULL
12	NULL
are	NULL
DNasel-generated	NULL
fragments	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
HMG	NULL
I/	NULL
Y	NULL
.	NULL

Lanes	NULL
3-5	NULL
and	NULL
9-11	NULL
contain	NULL
increasing	NULL
amounts	NULL
of	NULL
HMG	NULL
I/Y	NULL
.	NULL

Six	NULL
protected	NULL
regions	NULL
are	NULL
labeled	NULL
A-F.	NULL
(	NULL
B	NULL
)	NULL
Sequence	NULL
of	NULL
the	NULL
HLA-DRA	NULL
proximal	NULL
promoter	NULL
showing	NULL
the	NULL
regions	NULL
footprinted	NULL
by	NULL
HMG	NULL
I/Y	NULL
binding	NULL
.	NULL

Site	NULL
A	NULL
coincides	NULL
with	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
,	NULL
site	NULL
B	NULL
with	NULL
the	NULL
TATA	NULL
element	NULL
,	NULL
site	NULL
C	NULL
with	NULL
the	NULL
octamer	NULL
motif	NULL
,	NULL
site	NULL
D	NULL
with	NULL
the	NULL
A/T-rich	NULL
interspace	NULL
region	NULL
between	NULL
the	NULL
X	NULL
and	NULL
Y	NULL
boxes	NULL
,	NULL
and	NULL
two	NULL
upstream	NULL
binding	NULL
sites	NULL
(	NULL
E	NULL
and	NULL
F	NULL
)	NULL
that	NULL
are	NULL
located	NULL
in	NULL
a	NULL
region	NULL
which	NULL
is	NULL
dispensable	NULL
for	NULL
tissue-specific	NULL
and	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
ai	NULL
HLA-DRA	NULL
promoter	NULL
.	NULL

promoter	NULL
in	NULL
Hela	NULL
cells	NULL
occurs	NULL
via	NULL
an	NULL
Oct-2-independent	NULL
pathway	NULL
.	NULL

Thus	NULL
the	NULL
modest	NULL
effects	NULL
of	NULL
the	NULL
octamer	NULL
mutation	NULL
seen	NULL
on	NULL
inducibility	NULL
in	NULL
Hela	NULL
cells	NULL
is	NULL
more	NULL
likely	NULL
to	NULL
be	NULL
due	NULL
to	NULL
the	NULL
impairment	NULL
of	NULL
another	NULL
factor	NULL
,	NULL
which	NULL
we	NULL
feel	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
HMG	NULL
I/Y	NULL
itself	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
model	NULL
,	NULL
we	NULL
have	NULL
observed	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
s	NULL
that	NULL
a	NULL
high	NULL
mobility	NULL
complex	NULL
which	NULL
forms	NULL
on	NULL
the	NULL
DRA	NULL
octamer	NULL
element	NULL
is	NULL
enhanced	NULL
when	NULL
extracts	NULL
from	NULL
IFN-y-induced	NULL
Hela	NULL
cells	NULL
are	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
D	NULL
;	NULL
compare	NULL
lane	NULL
2	NULL
with	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
appears	NULL
to	NULL
contain	NULL
HMG	NULL
I/Y	NULL
or	NULL
an	NULL
immunologi-cally	NULL
related	NULL
protein	NULL
as	NULL
judged	NULL
by	NULL
its	NULL
sensitivity	NULL
to	NULL
antisera	NULL
raised	NULL
against	NULL
recombinant	NULL
HMG	NULL
I	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
E	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
suggests	NULL
that	NULL
induction	NULL
of	NULL
Hela	NULL
cells	NULL
with	NULL
IFN-y	NULL
enhances	NULL
the	NULL
binding	NULL
of	NULL
HMG	NULL
I	NULL
or	NULL
an	NULL
HMG	NULL
I-containing	NULL
complex	NULL
to	NULL
the	NULL
DRA	NULL
octamer	NULL
and	NULL
suggests	NULL
that	NULL
the	NULL
slight	NULL
impairment	NULL
in	NULL
IFN-y	NULL
inducibility	NULL
of	NULL
the	NULL
ABZCAT	NULL
reporter	NULL
may	NULL
result	NULL
from	NULL
inhibition	NULL
of	NULL
HMG	NULL
I/Y	NULL
binding	NULL
.	NULL

The	NULL
High	NULL
Mobility	NULL
Group	NULL
Protein	NULL
HMG	NULL
I/Y	NULL
Binds	NULL
to	NULL
Multiple	NULL
Sites	NULL
in	NULL
the	NULL
HLA-DR	NULL
A	NULL
Promoter	NULL
,	NULL
Including	NULL
the	NULL
Octamer-binding	NULL
Site	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
in	NULL
fact	NULL
shown	NULL
that	NULL
the	NULL
492	NULL
Roles	NULL
of	NULL
High	NULL
Mobility	NULL
Group	NULL
Protein	NULL
I/Y	NULL
and	NULL
Oct-2	NULL
in	NULL
HLA-DRA	NULL
Transcription	NULL
A	NULL
HLA-DRA	NULL
PROMOTER	NULL
MUTANTS	NULL
xo	NULL
AB2	NULL
CDH	NULL
Free	NULL
probe	NULL
#	NULL
»	NULL
EFl	NULL
EF	NULL
2	NULL
%	NULL
CAT	NULL
Activity	NULL
Basic	NULL
-	NULL
WT	NULL
WT	NULL
(	NULL
)	NULL
AB2	NULL
COH	NULL
CDI	NULL
EFf1	NULL
EF2	NULL
HMG	NULL
I/Y	NULL
protein	NULL
can	NULL
interact	NULL
with	NULL
the	NULL
octamer	NULL
element	NULL
of	NULL
the	NULL
human	NULL
Ig	NULL
L	NULL
promoter	NULL
(	NULL
49	NULL
)	NULL
.	NULL

The	NULL
DRA	NULL
promoter	NULL
contains	NULL
an	NULL
octamer	NULL
element	NULL
,	NULL
as	NULL
well	NULL
as	NULL
several	NULL
AT	NULL
-rich	NULL
regions	NULL
,	NULL
which	NULL
are	NULL
potential	NULL
HMG	NULL
I/Y¥-binding	NULL
sites	NULL
.	NULL

To	NULL
precisely	NULL
map	NULL
the	NULL
HMG	NULL
I/¥-binding	NULL
sites	NULL
within	NULL
this	NULL
region	NULL
we	NULL
carried	NULL
out	NULL
DNAse	NULL
I	NULL
footprinting	NULL
experiments	NULL
using	NULL
recombinant	NULL
HMG	NULL
I/Y	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
)	NULL
.	NULL

Six	NULL
binding	NULL
sites	NULL
,	NULL
designated	NULL
A-F	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
,	NULL
were	NULL
identified	NULL
on	NULL
both	NULL
the	NULL
coding	NULL
and	NULL
noncoding	NULL
strands	NULL
.	NULL

These	NULL
sites	NULL
coincide	NULL
with	NULL
:	NULL
(	NULL
A4	NULL
)	NULL
the	NULL
transcription	NULL
ini-	NULL
493	NULL
Abdulkadir	NULL
et	NULL
al	NULL
.	NULL

Tmmexm	NULL
)	NULL
[	NULL
amcxm	NULL
]	NULL
[	NULL
mral	NULL
-	NULL
[	NULL
CA__	NULL
Figure	NULL
4	NULL
.	NULL

-	NULL
The	NULL
effect	NULL
of	NULL
mutations	NULL
in	NULL
HMG	NULL
I/Y-binding	NULL
sites	NULL
on	NULL
DRA	NULL
expression	NULL
.	NULL

(	NULL
4	NULL
)	NULL
A	NULL
diagram	NULL
showing	NULL
mutations	NULL
introduced	NULL
into	NULL
two	NULL
HMG	NULL
I/Y-binding	NULL
sites	NULL
in	NULL
the	NULL
DRA	NULL
promoter	NULL
.	NULL

Substituted	NULL
bases	NULL
are	NULL
arrowed	NULL
.	NULL

AB2	NULL
contains	NULL
the	NULL
octamer	NULL
mutation	NULL
as	NULL
indicated	NULL
previously	NULL
.	NULL

CDH	NULL
and	NULL
CDI	NULL
are	NULL
D	NULL
box	NULL
(	NULL
inter-space	NULL
)	NULL
mutants	NULL
,	NULL
while	NULL
EF1	NULL
and	NULL
EF2	NULL
are	NULL
double	NULL
mutants	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Gel-shift	NULL
assay	NULL
comparing	NULL
the	NULL
binding	NULL
of	NULL
recombinant	NULL
HMG	NULL
I/Y	NULL
to	NULL
wild-type	NULL
octamer	NULL
(	NULL
OCT	NULL
)	NULL
and	NULL
D	NULL
box	NULL
interspace	NULL
(	NULL
IS	NULL
)	NULL
and	NULL
mutant	NULL
octamer	NULL
(	NULL
MOCT	NULL
)	NULL
and	NULL
mutant	NULL
D	NULL
box	NULL
(	NULL
MIS	NULL
)	NULL
oligos	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Results	NULL
of	NULL
CAT	NULL
assay	NULL
showing	NULL
the	NULL
effect	NULL
of	NULL
HMG	NULL
I/Y-binding	NULL
site	NULL
mutations	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
DRA	NULL
promoter	NULL
in	NULL
Hela	NULL
cells	NULL
induced	NULL
with	NULL
IFN-y	NULL
.	NULL

The	NULL
lane	NULL
marked	NULL
basic	NULL
refers	NULL
to	NULL
extract	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
promoterless	NULL
CAT	NULL
plasmid	NULL
pCAT	NULL
Basic	NULL
.	NULL

WT	NULL
refers	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
wild-type	NULL
DRA300CAT	NULL
plasmid	NULL
.	NULL

AB2CAT	NULL
,	NULL
CDHCAT	NULL
,	NULL
and	NULL
CDICAT	NULL
are	NULL
single	NULL
mutants	NULL
,	NULL
while	NULL
EF1CAT	NULL
and	NULL
EF2CAT	NULL
are	NULL
double	NULL
mutants	NULL
.	NULL

CAT	NULL
activity	NULL
,	NULL
averaged	NULL
from	NULL
triplicate	NULL
transfections	NULL
,	NULL
is	NULL
shown	NULL
.	NULL

(	NULL
-	NULL
)	NULL
Extracts	NULL
from	NULL
uninduced	NULL
cells	NULL
.	NULL

tiation	NULL
site	NULL
,	NULL
(	NULL
B	NULL
)	NULL
the	NULL
TATA-element	NULL
,	NULL
(	NULL
C	NULL
)	NULL
the	NULL
octamer	NULL
motif	NULL
,	NULL
(	NULL
D	NULL
)	NULL
the	NULL
A/T	NULL
-rich	NULL
region	NULL
located	NULL
between	NULL
the	NULL
X	NULL
and	NULL
Y	NULL
boxes	NULL
,	NULL
and	NULL
(	NULL
E	NULL
and	NULL
F	NULL
)	NULL
two	NULL
additional	NULL
sites	NULL
between	NULL
-250	NULL
and	NULL
-200	NULL
.	NULL

As	NULL
would	NULL
be	NULL
expected	NULL
from	NULL
the	NULL
known	NULL
sequence	NULL
preference	NULL
of	NULL
HMG	NULL
I/Y	NULL
,	NULL
all	NULL
of	NULL
these	NULL
binding	NULL
sites	NULL
are	NULL
A/T	NULL
rich	NULL
.	NULL

The	NULL
two	NULL
upstream	NULL
sites	NULL
,	NULL
E	NULL
and	NULL
F	NULL
,	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
HLA-DRA	NULL
gene	NULL
expression	NULL
,	NULL
since	NULL
reporter	NULL
constructs	NULL
lacking	NULL
these	NULL
sites	NULL
exhibit	NULL
proper	NULL
tissue-specific	NULL
and	NULL
inducible	NULL
expression	NULL
patterns	NULL
(	NULL
14	NULL
,	NULL
31	NULL
,	NULL
50	NULL
)	NULL
.	NULL

To	NULL
further	NULL
charac-	NULL
A	NULL
___	NULL
,	NULL
8	NULL
prasoocat	NULL
___________	NULL
|	NULL
&	NULL
ipl	NULL
|	NULL
e	NULL
A	NULL
e	NULL
?	NULL

\	NULL
ecuelint	NULL
}	NULL
;	NULL
t	NULL
'	NULL
A	NULL
ae	NULL
!	NULL

o	NULL
_n	NULL
ETP	NULL
ust	NULL
uNCaP	NULL
eq	NULL
)	NULL
@	NULL
\	NULL
,	NULL
@	NULL
@	NULL
per	NULL
ar	NULL
wr	NULL
cop	NULL
opt	NULL
-	NULL
.on	NULL
[	NULL
@	NULL
y	NULL
pont	NULL
09	NULL
petite	NULL
iet	NULL
?	NULL

kte	NULL
AC	NULL
CC	NULL
oF	NULL
oP	NULL
``	NULL
196	NULL
29h	NULL
``	NULL
494	NULL
``	NULL
49P	NULL
C	NULL
0	NULL
C	NULL
tib	NULL
C	NULL
&	NULL
©	NULL
_	NULL
%	NULL
a	NULL
£	NULL
%	NULL
Figure	NULL
5	NULL
.	NULL

-	NULL
Antisense	NULL
HMG	NULL
I/Y	NULL
RNA	NULL
inhibits	NULL
IFN-y	NULL
induction	NULL
of	NULL
the	NULL
HLA-DRA	NULL
gene	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Raji	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
plasmids	NULL
and	NULL
CAT	NULL
expression	NULL
assessed	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

The	NULL
lanes	NULL
marked	NULL
pHGCAT	NULL
and	NULL
DRA300CAT	NULL
were	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
those	NULL
plasmids	NULL
alone	NULL
.	NULL

The	NULL
other	NULL
lanes	NULL
were	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
both	NULL
the	NULL
DRA300CAT	NULL
reporter	NULL
plasmid	NULL
and	NULL
the	NULL
indicated	NULL
antisense	NULL
expression	NULL
vector	NULL
.	NULL

The	NULL
plasmids	NULL
:	NULL
pAhXBP1	NULL
,	NULL
pAfos	NULL
,	NULL
and	NULL
pAHMHMGI/Y	NULL
,	NULL
each	NULL
contain	NULL
either	NULL
the	NULL
entire	NULL
or	NULL
portions	NULL
of	NULL
the	NULL
coding	NULL
regions	NULL
of	NULL
the	NULL
hXBP1	NULL
,	NULL
c-fos	NULL
,	NULL
and	NULL
HMG	NULL
I/Y	NULL
genes	NULL
inserted	NULL
in	NULL
the	NULL
antisense	NULL
orientation	NULL
in	NULL
mammalian	NULL
expression	NULL
vectors	NULL
.	NULL

Antisense	NULL
hXBP1	NULL
and	NULL
c-fos	NULL
RNA	NULL
inhibit	NULL
transcription	NULL
from	NULL
the	NULL
DRA300CAT	NULL
reporter	NULL
construct	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Antisense	NULL
HMG	NULL
I/Y	NULL
and	NULL
BZLF1	NULL
RNA	NULL
have	NULL
no	NULL
effect	NULL
on	NULL
DRA	NULL
transcription	NULL
.	NULL

Results	NULL
from	NULL
duplicate	NULL
transfections	NULL
are	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
HeLa	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
DRA300CAT	NULL
plasmid	NULL
were	NULL
induced	NULL
with	NULL
recombinant	NULL
IFN-y	NULL
(	NULL
except	NULL
the	NULL
lane	NULL
marked	NULL
-IPN-y	NULL
)	NULL
.	NULL

As	NULL
in	NULL
A	NULL
,	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
various	NULL
antisense	NULL
vectors	NULL
(	NULL
as	NULL
indicated	NULL
)	NULL
.	NULL

In	NULL
these	NULL
cells	NULL
,	NULL
antisense	NULL
HMG	NULL
I/Y	NULL
RNA	NULL
(	NULL
in	NULL
addition	NULL
to	NULL
antisense	NULL
hXBP1	NULL
and	NULL
c-fos	NULL
RNA	NULL
)	NULL
is	NULL
able	NULL
to	NULL
inhibit	NULL
induction	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

terize	NULL
these	NULL
binding	NULL
sites	NULL
,	NULL
we	NULL
decided	NULL
to	NULL
study	NULL
the	NULL
effects	NULL
of	NULL
mutations	NULL
that	NULL
affect	NULL
HMG	NULL
I/Y	NULL
binding	NULL
to	NULL
these	NULL
sites	NULL
on	NULL
DRA	NULL
expression	NULL
.	NULL

Unfortunately	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
mutations	NULL
in	NULL
the	NULL
A	NULL
and	NULL
B	NULL
boxes	NULL
could	NULL
not	NULL
be	NULL
tested	NULL
,	NULL
since	NULL
these	NULL
mutations	NULL
would	NULL
be	NULL
expected	NULL
to	NULL
disrupt	NULL
transcriptional	NULL
initiation	NULL
and	NULL
TATA	NULL
box	NULL
function	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
mutations	NULL
in	NULL
the	NULL
octamer	NULL
(	NULL
C	NULL
box	NULL
)	NULL
and	NULL
the	NULL
D	NULL
box	NULL
,	NULL
were	NULL
thus	NULL
studied	NULL
.	NULL

We	NULL
used	NULL
DRA	NULL
reporter	NULL
constructs	NULL
that	NULL
contained	NULL
mutations	NULL
at	NULL
these	NULL
single	NULL
sites	NULL
as	NULL
well	NULL
as	NULL
double	NULL
mutants	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
)	NULL
.	NULL

These	NULL
mutations	NULL
abolish	NULL
HMG	NULL
I/Y	NULL
binding	NULL
in	NULL
vitro	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
these	NULL
mutations	NULL
on	NULL
B	NULL
cells	NULL
,	NULL
as	NULL
well	NULL
as	NULL
inducible	NULL
expression	NULL
in	NULL
Hela	NULL
cells	NULL
,	NULL
were	NULL
studied	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
all	NULL
the	NULL
constructs	NULL
containing	NULL
octamer	NULL
mutations	NULL
had	NULL
severely	NULL
impaired	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
while	NULL
the	NULL
D	NULL
box	NULL
mutations	NULL
had	NULL
only	NULL
modest	NULL
effects	NULL
on	NULL
B	NULL
cell-specific	NULL
or	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
HLA-DR	NULL
A	NULL
reporter	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
C	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Significantly	NULL
,	NULL
however	NULL
,	NULL
while	NULL
neither	NULL
the	NULL
octamer	NULL
mutation	NULL
nor	NULL
the	NULL
D	NULL
box	NULL
mutation	NULL
alone	NULL
greatly	NULL
impaired	NULL
IFN-y-inducible	NULL
expression	NULL
in	NULL
Hela	NULL
cells	NULL
,	NULL
A	NULL
HELA	NULL
CELLS	NULL
B	NULL
200	NULL
DRA3OOCAT	NULL
_	NULL
DQB2500CAT	NULL
&	NULL
4	NULL
S	NULL
G	NULL
``	NULL
Su	NULL
N	NULL
u	NULL
t	NULL
,	NULL
T	NULL
AX	NULL
sA	NULL
u	NULL
tof	NULL
8	NULL
(	NULL
G	NULL
)	NULL
A	NULL
A	NULL
ACA	NULL
A	NULL
A	NULL
AA	NULL
o	NULL
_	NULL
-	NULL
CPPCC	NULL
F	NULL
roo	NULL
``	NULL
C	NULL
``	NULL
6	NULL
``	NULL
C	NULL
©	NULL
£3	NULL
to	NULL
@	NULL
eeee0e	NULL
ee	NULL
00000	NULL
|	NULL
a	NULL
0	NULL
constructs	NULL
containing	NULL
mutations	NULL
at	NULL
both	NULL
sites	NULL
showed	NULL
a	NULL
severely	NULL
reduced	NULL
level	NULL
of	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
multiple	NULL
HMG	NULL
I/Y-binding	NULL
sites	NULL
may	NULL
be	NULL
required	NULL
for	NULL
IFN-y-inducible	NULL
expression	NULL
of	NULL
the	NULL
DRA	NULL
promoter	NULL
.	NULL

The	NULL
Effect	NULL
of	NULL
Antisense	NULL
HMG	NULL
I/Y	NULL
RNA	NULL
on	NULL
HLA-DRA	NULL
B	NULL
Cell-specific	NULL
and	NULL
Inducible	NULL
Expression	NULL
.	NULL

-	NULL
We	NULL
carried	NULL
out	NULL
experiments	NULL
using	NULL
antisense	NULL
HMG	NULL
I/	NULL
Y	NULL
RNA	NULL
to	NULL
further	NULL
investigate	NULL
a	NULL
possible	NULL
role	NULL
of	NULL
HMG	NULL
I/Y	NULL
in	NULL
constitutive	NULL
and	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
HLA-DRA	NULL
gene	NULL
.	NULL

Raji	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
HLA-DRA3OO0	NULL
reporter	NULL
construct	NULL
and	NULL
a	NULL
plasmid	NULL
directing	NULL
the	NULL
expression	NULL
of	NULL
antisense	NULL
HMG	NULL
I/Y	NULL
RNA	NULL
,	NULL
and	NULL
no	NULL
effect	NULL
on	NULL
HLA-DRA	NULL
expression	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
A	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
as	NULL
we	NULL
previously	NULL
reported	NULL
,	NULL
antisense	NULL
hXBP-1	NULL
and	NULL
c-fos	NULL
RNA	NULL
expression	NULL
decreased	NULL
transcription	NULL
from	NULL
the	NULL
DRA30O0OCAT	NULL
reporter	NULL
construct	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

These	NULL
results	NULL
might	NULL
suggest	NULL
that	NULL
HMG	NULL
I/Y	NULL
is	NULL
not	NULL
required	NULL
for	NULL
B	NULL
cell-specific	NULL
expression	NULL
of	NULL
HLA-DRA	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
antisense	NULL
RNA	NULL
might	NULL
not	NULL
effectively	NULL
block	NULL
the	NULL
expression	NULL
of	NULL
HMG	NULL
I/Y	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

A	NULL
dramatically	NULL
different	NULL
result	NULL
was	NULL
obtained	NULL
when	NULL
the	NULL
an	NULL
Figure	NULL
6	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
by	NULL
the	NULL
octamer-binding	NULL
transcription	NULL
factor	NULL
Oct-2A	NULL
and	NULL
its	NULL
cooperation	NULL
with	NULL
HMG	NULL
I/Y	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Either	NULL
the	NULL
DRA300CAT	NULL
or	NULL
DQB2500CAT	NULL
reporter	NULL
plasmid	NULL
was	NULL
transfected	NULL
into	NULL
the	NULL
MHC	NULL
class	NULL
II-negative	NULL
,	NULL
Oct-2-negative	NULL
cell	NULL
line	NULL
Hela	NULL
,	NULL
alone	NULL
(	NULL
lanes	NULL
marked	NULL
-	NULL
)	NULL
or	NULL
with	NULL
mammalian	NULL
expression	NULL
vectors	NULL
encoding	NULL
Oct1	NULL
or	NULL
Oct2	NULL
.	NULL

Overexpression	NULL
of	NULL
Oct2	NULL
selectively	NULL
transactivates	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
.	NULL

Results	NULL
of	NULL
duplicate	NULL
transfections	NULL
are	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Oct-2	NULL
transactivates	NULL
DRA300OCAT	NULL
in	NULL
the	NULL
Oct-2-negative	NULL
,	NULL
MHC	NULL
class	NULL
II-negative	NULL
cell	NULL
line	NULL
Jurkat	NULL
,	NULL
and	NULL
this	NULL
transactivation	NULL
is	NULL
facilitated	NULL
by	NULL
HMG	NULL
I/Y	NULL
overexpression	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
trausfected	NULL
with	NULL
DRA300OCAT	NULL
and	NULL
the	NULL
indicated	NULL
expression	NULL
vectors	NULL
and	NULL
CAT	NULL
activity	NULL
was	NULL
assessed	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

The	NULL
y-axis	NULL
indicates	NULL
CAT	NULL
activity	NULL
in	NULL
extracts	NULL
from	NULL
these	NULL
cells	NULL
relative	NULL
to	NULL
CAT	NULL
activity	NULL
in	NULL
DRA300CAT	NULL
transfected	NULL
Jijoye	NULL
cells	NULL
(	NULL
DR	NULL
A300CAT-mediated	NULL
activity	NULL
in	NULL
Jiyoye	NULL
cells	NULL
results	NULL
in	NULL
23	NULL
%	NULL
transacetylation	NULL
)	NULL
.	NULL

The	NULL
data	NULL
are	NULL
from	NULL
three	NULL
independent	NULL
transfections	NULL
.	NULL

MB	NULL
,	NULL
pHGCAT	NULL
;	NULL
&	NULL
,	NULL
DRACAT	NULL
;	NULL
§	NULL
,	NULL
DRACAT	NULL
+	NULL
Oct-1	NULL
;	NULL
[	NULL
J	NULL
,	NULL
DRCAT	NULL
+	NULL
Oct-2A	NULL
;	NULL
}	NULL
,	NULL
DRACAT	NULL
+	NULL
HMG	NULL
1	NULL
;	NULL
@	NULL
,	NULL
DRACAT	NULL
+	NULL
HMG	NULL
1	NULL
+	NULL
Oct-1	NULL
;	NULL
§	NULL
,	NULL
DRACAT	NULL
+	NULL
HMG	NULL
1	NULL
+	NULL
Oct-2A	NULL
.	NULL

494	NULL
Roles	NULL
of	NULL
High	NULL
Mobility	NULL
Group	NULL
Protein	NULL
I/Y	NULL
and	NULL
Oct-2	NULL
in	NULL
HLA-DRA	NULL
Transcription	NULL
+	NULL
HMG	NULL
I	NULL
-	NULL
HMG	NULL
J	NULL
A	NULL
1	NULL
J	NULL
C	NULL
--	NULL
“	NULL
lib—J	NULL
Oct-1	NULL
-	NULL
#	NULL
-Oct-2A	NULL
-	NULL
»	NULL
HMG	NULL
1	NULL
-*-Octamert	NULL
»	NULL
-	NULL
10	NULL
20	NULL
30	NULL
4	NULL
S	NULL
6	NULL
7	NULL
as	NULL
9	NULL
10	NULL
11	NULL
UJ	NULL
:	NULL
-HMG	NULL
I	NULL
Ratio	NULL
of	NULL
complex	NULL
formed	NULL
+HMG	NULL
I	NULL
4	NULL
7	NULL
0	NULL
°	NULL
``	NULL
T	NULL
*	NULL
T	NULL
T	NULL
T	NULL
i	NULL
l	NULL
1.0	NULL
1.5	NULL
2.0	NULL
Amount	NULL
of	NULL
extract	NULL
(	NULL
ug	NULL
)	NULL
Figure	NULL
7	NULL
.	NULL

HMG	NULL
I/Y	NULL
selectively	NULL
facilitates	NULL
interaction	NULL
of	NULL
Oct-2	NULL
with	NULL
the	NULL
HLA-DRA	NULL
octamer	NULL
motif	NULL
in	NULL
EMSAs	NULL
.	NULL

(	NULL
4	NULL
)	NULL
The	NULL
influence	NULL
of	NULL
recombinant	NULL
HMG	NULL
I	NULL
on	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
binding	NULL
to	NULL
the	NULL
HLA-DRA	NULL
octamer	NULL
motif	NULL
was	NULL
assessed	NULL
in	NULL
EMSAs	NULL
using	NULL
Jijoye	NULL
extracts	NULL
that	NULL
contain	NULL
both	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
.	NULL

Decreasing	NULL
amounts	NULL
of	NULL
Jijoye	NULL
whole-cell	NULL
extract	NULL
(	NULL
10	NULL
ug-0.1	NULL
ug	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
fixed	NULL
amount	NULL
of	NULL
the	NULL
radiolabeled	NULL
octamer	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
{	NULL
lanes	NULL
4-7	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
lanes	NULL
8-11	NULL
)	NULL
of	NULL
0.1	NULL
ug	NULL
of	NULL
recombinant	NULL
HMG	NULL
I	NULL
.	NULL

Lane	NULL
1	NULL
contains	NULL
free	NULL
probe	NULL
,	NULL
lane	NULL
2	NULL
contains	NULL
only	NULL
recombinant	NULL
HMG	NULL
1	NULL
,	NULL
lane	NULL
3	NULL
contains	NULL
only	NULL
Jijoye	NULL
extract	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
major	NULL
retarded	NULL
complexes	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

The	NULL
recombinant	NULL
HMG	NULL
I	NULL
complex	NULL
comigrates	NULL
with	NULL
a	NULL
complex	NULL
observed	NULL
in	NULL
Jijoye	NULL
extracts	NULL
(	NULL
which	NULL
may	NULL
be	NULL
endogenous	NULL
HMG	NULL
I/Y	NULL
)	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
the	NULL
Oct-2A-containing	NULL
complex	NULL
is	NULL
selectively	NULL
enhanced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
HMG	NULL
I	NULL
,	NULL
especially	NULL
at	NULL
lower	NULL
concentrations	NULL
of	NULL
extract	NULL
(	NULL
compare	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
to	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
efficiency	NULL
of	NULL
Oct-1	NULL
and	NULL
Oct-2A	NULL
complex	NULL
formation	NULL
in	NULL
the	NULL
various	NULL
conditions	NULL
were	NULL
determined	NULL
by	NULL
densitometry	NULL
and	NULL
the	NULL
results	NULL
are	NULL
shown	NULL
in	NULL
this	NULL
graph	NULL
.	NULL

The	NULL
y-axis	NULL
represents	NULL
the	NULL
ratio	NULL
of	NULL
octamer-binding	NULL
complex	NULL
formation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
HMG	NULL
I	NULL
to	NULL
that	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
HMG	NULL
I	NULL
.	NULL

The	NULL
x-axis	NULL
represents	NULL
the	NULL
amount	NULL
of	NULL
whole-cell	NULL
extract	NULL
used	NULL
in	NULL
each	NULL
reaction	NULL
.	NULL

OCT	NULL
1	NULL
;	NULL
-A-	NULL
,	NULL
OCT	NULL
2A	NULL
.	NULL

tisense	NULL
RNA	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
HeLa	NULL
cells	NULL
induced	NULL
with	NULL
IFN-y	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
B	NULL
,	NULL
expression	NULL
of	NULL
antisense	NULL
HMG	NULL
I/Y	NULL
RNA	NULL
in	NULL
HeLa	NULL
cells	NULL
abolishes	NULL
IFN-y	NULL
induction	NULL
of	NULL
the	NULL
HLA-DR	NULL
reporter	NULL
construct	NULL
.	NULL

This	NULL
obser-vation	NULL
,	NULL
in	NULL
conjunction	NULL
with	NULL
the	NULL
results	NULL
of	NULL
the	NULL
mutations	NULL
in	NULL
the	NULL
HMG	NULL
I/	NULL
¥-binding	NULL
sites	NULL
of	NULL
the	NULL
HLA-DR	NULL
gene	NULL
,	NULL
indicates	NULL
that	NULL
HMG	NULL
I/	NULL
Y	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
HLA-DRA	NULL
gene	NULL
expression	NULL
by	NULL
IFN-y	NULL
.	NULL

Oct2A	NULL
Is	NULL
a	NULL
Transactivator	NULL
of	NULL
the	NULL
HLA-DRA	NULL
Gene	NULL
and	NULL
Cooperates	NULL
with	NULL
HMG	NULL
I/Y	NULL
.	NULL

-	NULL
As	NULL
we	NULL
have	NULL
shown	NULL
above	NULL
,	NULL
the	NULL
Oct-2	NULL
protein	NULL
is	NULL
required	NULL
for	NULL
constitutive	NULL
expression	NULL
of	NULL
the	NULL
DRA	NULL
gene	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
transfected	NULL
Oct-2	NULL
expression	NULL
vector	NULL
can	NULL
mediate	NULL
activation	NULL
of	NULL
HLA-DRA	NULL
gene	NULL
expression	NULL
in	NULL
an	NULL
Oct-2-negative	NULL
,	NULL
class	NULL
II-negative	NULL
cell	NULL
line	NULL
,	NULL
we	NULL
cotransfected	NULL
the	NULL
HLA-DR	NULL
A300	NULL
reporter	NULL
construct	NULL
and	NULL
an	NULL
Oct-2A	NULL
expression	NULL
vector	NULL
into	NULL
either	NULL
Hela	NULL
or	NULL
Jurkat	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
,	NULL
when	NULL
increasing	NULL
amounts	NULL
of	NULL
the	NULL
Oct-2	NULL
expression	NULL
vector	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
reporter	NULL
into	NULL
Hela	NULL
cells	NULL
,	NULL
significant	NULL
levels	NULL
of	NULL
CAT	NULL
activity	NULL
were	NULL
observed	NULL
.	NULL

The	NULL
reporter	NULL
gene	NULL
was	NULL
not	NULL
activated	NULL
when	NULL
an	NULL
Oct-1	NULL
expression	NULL
plasmid	NULL
was	NULL
cotransfected	NULL
with	NULL
the	NULL
reporter	NULL
gene	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
DQB	NULL
promoter	NULL
,	NULL
which	NULL
we	NULL
have	NULL
shown	NULL
does	NULL
not	NULL
require	NULL
Oct-2	NULL
for	NULL
its	NULL
expression	NULL
in	NULL
B-cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
is	NULL
not	NULL
transactivated	NULL
by	NULL
overexpression	NULL
of	NULL
either	NULL
Oct-1	NULL
or	NULL
Oct-2A	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
Oct-2A	NULL
,	NULL
but	NULL
not	NULL
Oct-1	NULL
,	NULL
also	NULL
activated	NULL
expression	NULL
of	NULL
the	NULL
HLA-DRA	NULL
reporter	NULL
plasmid	NULL
in	NULL
the	NULL
class	NULL
II-negative	NULL
cell	NULL
line	NULL
Jurkat	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
)	NULL
.	NULL

Since	NULL
HMG	NULL
I/Y	NULL
also	NULL
495	NULL
Abdulkadir	NULL
et	NULL
al	NULL
.	NULL

interacts	NULL
with	NULL
the	NULL
octamer	NULL
element	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
effect	NULL
of	NULL
overexpressing	NULL
this	NULL
protein	NULL
on	NULL
DRA	NULL
promoter	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

We	NULL
found	NULL
that	NULL
overexpression	NULL
of	NULL
HMG	NULL
I/Y	NULL
alone	NULL
did	NULL
not	NULL
increase	NULL
the	NULL
level	NULL
of	NULL
HLA-DRA	NULL
promoter	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
coexpression	NULL
of	NULL
both	NULL
HMG	NULL
I/	NULL
Y	NULL
and	NULL
Oct-2A	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
HLA-DRA	NULL
promoter	NULL
activity	NULL
compared	NULL
with	NULL
the	NULL
effect	NULL
of	NULL
overexpressing	NULL
Oct-2A	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
)	NULL
.	NULL

HMG	NULL
I/Y	NULL
Selectively	NULL
Facilitates	NULL
Interaction	NULL
of	NULL
Oct-2A	NULL
with	NULL
the	NULL
HLA-DR	NULL
Octamer	NULL
Motif	NULL
.	NULL

-	NULL
To	NULL
explore	NULL
the	NULL
possible	NULL
mechanisms	NULL
by	NULL
which	NULL
HMG	NULL
I/Y	NULL
facilitates	NULL
DRA	NULL
transactivation	NULL
by	NULL
Oct-2	NULL
,	NULL
we	NULL
carried	NULL
out	NULL
EMSAs	NULL
to	NULL
assess	NULL
the	NULL
effect	NULL
of	NULL
HMG	NULL
I/Y	NULL
on	NULL
the	NULL
binding	NULL
of	NULL
Oct-2	NULL
to	NULL
the	NULL
octamer	NULL
element	NULL
.	NULL

Ini-tially	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
recombinant	NULL
HMG	NULL
I/Y	NULL
on	NULL
the	NULL
assembly	NULL
of	NULL
nucleoprotein	NULL
complexes	NULL
at	NULL
the	NULL
octamer	NULL
site	NULL
from	NULL
whole	NULL
cell	NULL
extracts	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
A	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
low	NULL
protein	NULL
concentrations	NULL
of	NULL
Jijoye	NULL
extracts	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
octamer	NULL
factors	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
is	NULL
undetectable	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
.	NULL

However	NULL
,	NULL
addition	NULL
of	NULL
a	NULL
fixed	NULL
amount	NULL
of	NULL
HMG	NULL
I/Y	NULL
(	NULL
0.1	NULL
ug	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
specific	NULL
enhancement	NULL
of	NULL
the	NULL
binding	NULL
of	NULL
Oct-2A	NULL
to	NULL
the	NULL
octamer	NULL
element	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
the	NULL
octamer	NULL
binding	NULL
proteins	NULL
Oct-1	NULL
and	NULL
Oct-2B	NULL
(	NULL
the	NULL
alternatively	NULL
spliced	NULL
form	NULL
of	NULL
Oct-2	NULL
which	NULL
migrates	NULL
with	NULL
an	NULL
intermediate	NULL
mobility	NULL
between	NULL
Oct-1	NULL
and	NULL
Oct-2A	NULL
;	NULL
51	NULL
,	NULL
52	NULL
)	NULL
are	NULL
not	NULL
facilitated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
additional	NULL
recombinant	NULL
HMG	NULL
I/Y	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
affinity	NULL
of	NULL
Oct-1	NULL
is	NULL
reduced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
HMG	NULL
I/Y	NULL
(	NULL
compare	NULL
lanes	NULL
6	NULL
and	NULL
10	NULL
)	NULL
.	NULL

Thus	NULL
the	NULL
presence	NULL
of	NULL
HMG	NULL
I/	NULL
Y	NULL
not	NULL
only	NULL
facilitates	NULL
the	NULL
binding	NULL
of	NULL
Oct	NULL
2A	NULL
to	NULL
the	NULL
octamer	NULL
element	NULL
but	NULL
actually	NULL
inhibits	NULL
the	NULL
binding	NULL
of	NULL
other	NULL
competing	NULL
proteins	NULL
such	NULL
as	NULL
Oct-1	NULL
.	NULL

To	NULL
quantitate	NULL
these	NULL
effects	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
abundance	NULL
of	NULL
each	NULL
complex	NULL
in	NULL
a	NULL
representative	NULL
experiment	NULL
by	NULL
densitometric	NULL
analysis	NULL
and	NULL
the	NULL
results	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
B	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
Oct-2A-containing	NULL
complex	NULL
is	NULL
enhanced	NULL
approximately	NULL
fourfold	NULL
at	NULL
low	NULL
concentrations	NULL
of	NULL
Jijoye	NULL
extract	NULL
.	NULL

A	NULL
more	NULL
striking	NULL
observation	NULL
is	NULL
that	NULL
the	NULL
ratio	NULL
of	NULL
Oct2A	NULL
to	NULL
Oct-1	NULL
complex	NULL
formation	NULL
is	NULL
shifted	NULL
90-	NULL
to	NULL
100-fold	NULL
in	NULL
favor	NULL
of	NULL
Oct-2A	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
recombinant	NULL
HMG	NULL
I/Y	NULL
.	NULL

These	NULL
effects	NULL
of	NULL
HMG	NULL
I/Y	NULL
may	NULL
have	NULL
been	NULL
due	NULL
either	NULL
to	NULL
the	NULL
direct	NULL
influence	NULL
of	NULL
HMG	NULL
I/Y	NULL
itself	NULL
,	NULL
or	NULL
might	NULL
have	NULL
been	NULL
mediated	NULL
by	NULL
other	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
present	NULL
in	NULL
Jijoye	NULL
extracts	NULL
.	NULL

To	NULL
distinguish	NULL
between	NULL
these	NULL
possibilities	NULL
,	NULL
we	NULL
performed	NULL
these	NULL
experiments	NULL
using	NULL
recombinant	NULL
Oct-1	NULL
or	NULL
Oct-2	NULL
proteins	NULL
.	NULL

We	NULL
first	NULL
tested	NULL
the	NULL
influence	NULL
of	NULL
HMG	NULL
I/Y	NULL
on	NULL
the	NULL
binding	NULL
of	NULL
recombinant	NULL
Oct-2A	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
A	NULL
,	NULL
HMG	NULL
I	NULL
significantly	NULL
enhances	NULL
the	NULL
binding	NULL
of	NULL
Oct-2A	NULL
to	NULL
the	NULL
HLA-DRA	NULL
octamer	NULL
at	NULL
low	NULL
Oct-2A	NULL
concentrations	NULL
.	NULL

In	NULL
sharp	NULL
contrast	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
in	NULL
vitro	NULL
translated	NULL
Oct-1	NULL
protein	NULL
was	NULL
inhibited	NULL
by	NULL
HMG	NULL
I/	NULL
Y	NULL
,	NULL
as	NULL
we	NULL
have	NULL
observed	NULL
with	NULL
B	NULL
cell-de-rived	NULL
Oct-1	NULL
in	NULL
EMSAs	NULL
using	NULL
crude	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
B	NULL
;	NULL
compare	NULL
lanes	NULL
2-4	NULL
with	NULL
lanes	NULL
5-7	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
strongly	NULL
suggest	NULL
that	NULL
HMG	NULL
I/Y	NULL
exerts	NULL
direct	NULL
and	NULL
opposing	NULL
effects	NULL
on	NULL
the	NULL
interaction	NULL
of	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
proteins	NULL
with	NULL
the	NULL
octamer	NULL
element	NULL
.	NULL

Discussion	NULL
The	NULL
MHC	NULL
class	NULL
II	NULL
gene	NULL
DRA	NULL
is	NULL
the	NULL
most	NULL
highly	NULL
expressed	NULL
of	NULL
the	NULL
human	NULL
class	NULL
HI	NULL
genes	NULL
,	NULL
and	NULL
the	NULL
HLA-DR	NULL
molecule	NULL
is	NULL
the	NULL
predominant	NULL
restriction	NULL
element	NULL
for	NULL
helper	NULL
T	NULL
cell	NULL
clones	NULL
(	NULL
1	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Aberrant	NULL
or	NULL
unusually	NULL
high	NULL
levels	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
class	NULL
II	NULL
molecules	NULL
have	NULL
also	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
various	NULL
autoimmune	NULL
diseases	NULL
,	NULL
such	NULL
as	NULL
multiple	NULL
scle-rosis	NULL
,	NULL
rheumatoid	NULL
arthritis	NULL
,	NULL
and	NULL
insulin-dependent	NULL
diabetes	NULL
A	NULL
+HMG	NULL
I	NULL
HMG	NULL
I	NULL
o	NULL
1T	NULL
Oct-2A	NULL
|	NULL
B	NULL
--	NULL
-	NULL
-	NULL
-	NULL
~-HMG	NULL
|	NULL
=-Octamer-	NULL
»	NULL
-	NULL
®	NULL
1	NULL
2	NULL
3	NULL
40	NULL
5	NULL
60	NULL
7	NULL
8	NULL
90	NULL
10	NULL
1	NULL
mellitus	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
expression	NULL
of	NULL
these	NULL
molecules	NULL
is	NULL
the	NULL
cause	NULL
of	NULL
the	NULL
severe	NULL
combined	NULL
immunodeficiency	NULL
disorder	NULL
,	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
.	NULL

The	NULL
transcriptional	NULL
regulation	NULL
of	NULL
these	NULL
genes	NULL
has	NULL
therefore	NULL
been	NULL
the	NULL
focus	NULL
of	NULL
intense	NULL
investigation	NULL
(	NULL
6	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
of	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
have	NULL
led	NULL
to	NULL
the	NULL
identification	NULL
of	NULL
conserved	NULL
elements	NULL
within	NULL
the	NULL
promoter	NULL
and	NULL
a	NULL
number	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
which	NULL
appear	NULL
to	NULL
participate	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
reviewed	NULL
in	NULL
13	NULL
)	NULL
.	NULL

An	NULL
octamer	NULL
element	NULL
has	NULL
been	NULL
found	NULL
in	NULL
two	NULL
human	NULL
class	NULL
II	NULL
MHC	NULL
genes	NULL
:	NULL
HLA-DRA	NULL
and	NULL
-DQB	NULL
.	NULL

While	NULL
there	NULL
have	NULL
been	NULL
reports	NULL
that	NULL
the	NULL
octamer	NULL
is	NULL
important	NULL
for	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
DRA	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
31	NULL
,	NULL
42	NULL
)	NULL
,	NULL
its	NULL
role	NULL
in	NULL
DQB	NULL
expression	NULL
had	NULL
not	NULL
been	NULL
assessed	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
have	NULL
confirmed	NULL
the	NULL
role	NULL
of	NULL
the	NULL
octamer	NULL
in	NULL
constitutive	NULL
expression	NULL
of	NULL
the	NULL
DRA	NULL
promoter	NULL
,	NULL
and	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
octamer-binding	NULL
protein	NULL
Oct-2A	NULL
is	NULL
critical	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
endogenous	NULL
DRA	NULL
gene	NULL
.	NULL

Neither	NULL
Oct-1	NULL
nor	NULL
Oct-2	NULL
appears	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
DQB	NULL
transcription	NULL
as	NULL
assessed	NULL
by	NULL
our	NULL
experiments	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
positioning	NULL
of	NULL
the	NULL
element	NULL
in	NULL
DQB	NULL
(	NULL
at	NULL
about	NULL
-600	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
)	NULL
,	NULL
compared	NULL
with	NULL
its	NULL
location	NULL
in	NULL
the	NULL
DRA	NULL
promoter	NULL
(	NULL
where	NULL
it	NULL
is	NULL
found	NULL
just	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
)	NULL
,	NULL
accounts	NULL
for	NULL
this	NULL
observation	NULL
.	NULL

We	NULL
can	NULL
not	NULL
of	NULL
course	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
element	NULL
plays	NULL
some	NULL
role	NULL
in	NULL
DQB	NULL
expression	NULL
at	NULL
some	NULL
point	NULL
during	NULL
development	NULL
or	NULL
in	NULL
a	NULL
specific	NULL
physiologic	NULL
setting	NULL
.	NULL

We	NULL
have	NULL
also	NULL
investigated	NULL
the	NULL
role	NULL
of	NULL
another	NULL
octamer-binding	NULL
protein	NULL
,	NULL
the	NULL
high	NULL
mobility	NULL
group	NULL
protein	NULL
HMG	NULL
I/	NULL
Y	NULL
,	NULL
in	NULL
HLA-DRA	NULL
transcription	NULL
.	NULL

We	NULL
have	NULL
found	NULL
that	NULL
HMG	NULL
I/Y	NULL
binds	NULL
to	NULL
six	NULL
sites	NULL
between	NULL
-300	NULL
bp	NULL
and	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
of	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
.	NULL

These	NULL
include	NULL
:	NULL
two	NULL
sites	NULL
upstream	NULL
of	NULL
-200	NULL
bp	NULL
,	NULL
an	NULL
AT	NULL
-rich	NULL
palindromic	NULL
motif	NULL
situated	NULL
between	NULL
the	NULL
X	NULL
and	NULL
the	NULL
Y	NULL
boxes	NULL
(	NULL
which	NULL
we	NULL
term	NULL
the	NULL
D	NULL
box	NULL
)	NULL
,	NULL
the	NULL
octamer	NULL
motif	NULL
,	NULL
the	NULL
TATA	NULL
box	NULL
,	NULL
and	NULL
a	NULL
site	NULL
that	NULL
overlaps	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
(	NULL
which	NULL
we	NULL
call	NULL
the	NULL
A	NULL
box	NULL
)	NULL
.	NULL

It	NULL
is	NULL
of	NULL
interest	NULL
that	NULL
some	NULL
of	NULL
these	NULL
sites	NULL
coincide	NULL
with	NULL
well-defined	NULL
cis	NULL
elements	NULL
that	NULL
bind	NULL
either	NULL
well-defined	NULL
regula-	NULL
Figure	NULL
8	NULL
.	NULL

Influence	NULL
of	NULL
HMG	NULL
I/Y	NULL
on	NULL
the	NULL
binding	NULL
of	NULL
Oct-2	NULL
and	NULL
Oct-1	NULL
.	NULL

(	NULL
4	NULL
)	NULL
The	NULL
influence	NULL
of	NULL
recombinant	NULL
HMG	NULL
I	NULL
on	NULL
recom-	NULL
binant	NULL
Oct-2/HLA-DRA	NULL
octamer	NULL
complex	NULL
formation	NULL
was	NULL
assessed	NULL
by	NULL
EMSA	NULL
.	NULL

Decreasing	NULL
amounts	NULL
(	NULL
10	NULL
ng-0.5	NULL
ng	NULL
)	NULL
of	NULL
recombinant	NULL
Oct-2A	NULL
protein	NULL
were	NULL
in	NULL
cubated	NULL
with	NULL
radiolabeled	NULL
DRA	NULL
octamer	NULL
<	NULL
»	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
lanes	NULL
2-6	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
lanes	NULL
7-11	NULL
)	NULL
of	NULL
10	NULL
ng	NULL
HMG	NULL
I	NULL
.	NULL

Total	NULL
amounts	NULL
of	NULL
protein	NULL
were	NULL
kept	NULL
constant	NULL
.	NULL

Lane	NULL
1	NULL
contains	NULL
free	NULL
probe	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
the	NULL
Oct	NULL
2A-containing	NULL
complex	NULL
is	NULL
selectively	NULL
en-	NULL
hanced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
HMG	NULL
I	NULL
,	NULL
espe-	NULL
cially	NULL
at	NULL
lower	NULL
concentrations	NULL
(	NULL
compare	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
to	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
has	NULL
showing	NULL
decreasing	NULL
amounts	NULL
of	NULL
in	NULL
vitro	NULL
y	NULL
``	NULL
WB	NULL
_	NULL
translated	NULL
Oct1	NULL
protein	NULL
incubated	NULL
with	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
or	NULL
without	NULL
(	NULL
lanes	NULL
5-7	NULL
)	NULL
100	NULL
ng	NULL
of	NULL
recombinant	NULL
HMG	NULL
I	NULL
.	NULL

Lane	NULL
8	NULL
contains	NULL
recombinant	NULL
HMG	NULL
I	NULL
alone	NULL
.	NULL

Lane	NULL
marked	NULL
I	NULL
contains	NULL
recombinant	NULL
HMG	NULL
I	NULL
alone	NULL
and	NULL
lane	NULL
marked	NULL
F	NULL
contains	NULL
free	NULL
probe	NULL
.	NULL

-HMG	NULL
I	NULL
+HMG	NULL
I	NULL
Roles	NULL
of	NULL
High	NULL
Mobility	NULL
Group	NULL
Protein	NULL
I/Y	NULL
and	NULL
Oct-2	NULL
in	NULL
HLA-DRA	NULL
Transcription	NULL
tory	NULL
DNA-binding	NULL
proteins	NULL
or	NULL
components	NULL
of	NULL
the	NULL
general	NULL
transcriptional	NULL
machinery	NULL
.	NULL

In	NULL
a	NULL
series	NULL
of	NULL
experiments	NULL
using	NULL
mammalian	NULL
expression	NULL
vectors	NULL
directing	NULL
the	NULL
expression	NULL
of	NULL
sense	NULL
or	NULL
antisense	NULL
HMG	NULL
I/Y	NULL
RNA	NULL
,	NULL
and	NULL
using	NULL
site-directed	NULL
mutants	NULL
of	NULL
the	NULL
promoter	NULL
to	NULL
assess	NULL
the	NULL
importance	NULL
of	NULL
individual	NULL
HMG	NULL
I/	NULL
¥-binding	NULL
sites	NULL
,	NULL
we	NULL
show	NULL
here	NULL
that	NULL
HMG	NULL
I/Y	NULL
is	NULL
essential	NULL
for	NULL
IFN-y	NULL
induction	NULL
of	NULL
the	NULL
DRA	NULL
gene	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Interestingly	NULL
,	NULL
treatment	NULL
of	NULL
Hela	NULL
cells	NULL
with	NULL
IFN-y	NULL
appears	NULL
to	NULL
enhance	NULL
HMG	NULL
I/¥-binding	NULL
activity	NULL
in	NULL
EMSAs	NULL
,	NULL
strengthening	NULL
the	NULL
notion	NULL
that	NULL
HMG	NULL
I/Y	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
mediating	NULL
IFN-y-inducible	NULL
expression	NULL
of	NULL
the	NULL
DRA	NULL
gene	NULL
.	NULL

We	NULL
do	NULL
not	NULL
at	NULL
this	NULL
point	NULL
know	NULL
why	NULL
IFN-y	NULL
induction	NULL
enhances	NULL
the	NULL
HMG	NULL
I/Y-containing	NULL
complex	NULL
,	NULL
although	NULL
it	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
result	NULL
from	NULL
induction	NULL
of	NULL
HMG	NULL
I/Y	NULL
itself	NULL
(	NULL
our	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
expression	NULL
of	NULL
antisense	NULL
HMG	NULL
I/Y	NULL
RNA	NULL
did	NULL
not	NULL
affect	NULL
DRA	NULL
promoter	NULL
activity	NULL
in	NULL
transiently	NULL
transfected	NULL
B	NULL
cell	NULL
lines	NULL
which	NULL
constitutively	NULL
express	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

Although	NULL
this	NULL
might	NULL
be	NULL
interpreted	NULL
to	NULL
indicate	NULL
that	NULL
HMG	NULL
I/Y	NULL
is	NULL
not	NULL
involved	NULL
in	NULL
DRA	NULL
transcription	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
we	NULL
feel	NULL
that	NULL
this	NULL
is	NULL
not	NULL
likely	NULL
in	NULL
view	NULL
of	NULL
the	NULL
strong	NULL
cooperativity	NULL
between	NULL
Oct-2A	NULL
and	NULL
HMG	NULL
I/Y	NULL
that	NULL
we	NULL
have	NULL
observed	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
in	NULL
these	NULL
experiments	NULL
.	NULL

Rather	NULL
,	NULL
we	NULL
suspect	NULL
that	NULL
the	NULL
inability	NULL
of	NULL
antisense	NULL
HMG	NULL
I/Y	NULL
RNA	NULL
to	NULL
block	NULL
DRA	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
higher	NULL
levels	NULL
of	NULL
HMG	NULL
I/	NULL
Y	NULL
in	NULL
these	NULL
cell	NULL
lines	NULL
compared	NULL
with	NULL
HeLa	NULL
cells	NULL
.	NULL

We	NULL
are	NULL
also	NULL
intrigued	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
DRA	NULL
reporter	NULL
constructs	NULL
containing	NULL
simultaneous	NULL
mutations	NULL
in	NULL
two	NULL
of	NULL
the	NULL
HMG	NULL
I/Y-binding	NULL
sites	NULL
(	NULL
the	NULL
octamer	NULL
and	NULL
the	NULL
D	NULL
box	NULL
)	NULL
exhibit	NULL
severely	NULL
impaired	NULL
IFN-y	NULL
inducibility	NULL
,	NULL
while	NULL
promoters	NULL
containing	NULL
single	NULL
mutations	NULL
in	NULL
these	NULL
sites	NULL
show	NULL
near-normal	NULL
levels	NULL
of	NULL
activity	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
mutations	NULL
in	NULL
multiple	NULL
HMG	NULL
I/	NULL
Y¥-binding	NULL
sites	NULL
are	NULL
needed	NULL
to	NULL
impair	NULL
IFN-y-induced	NULL
expression	NULL
suggests	NULL
that	NULL
the	NULL
multiple	NULL
HMG	NULL
I/Y	NULL
molecules	NULL
bound	NULL
at	NULL
various	NULL
sites	NULL
within	NULL
the	NULL
DRA	NULL
promoter	NULL
may	NULL
to	NULL
an	NULL
extent	NULL
be	NULL
redundant	NULL
,	NULL
providing	NULL
the	NULL
generic	NULL
function	NULL
of	NULL
facilitating	NULL
assembly	NULL
of	NULL
the	NULL
active	NULL
transcription	NULL
complex	NULL
.	NULL

This	NULL
would	NULL
almost	NULL
certainly	NULL
be	NULL
achieved	NULL
by	NULL
interactions	NULL
between	NULL
HMG	NULL
I/Y	NULL
molecules	NULL
bound	NULL
at	NULL
distinct	NULL
sites	NULL
or	NULL
between	NULL
HMG	NULL
I/Y	NULL
molecules	NULL
and	NULL
critical	NULL
activator	NULL
proteins	NULL
(	NULL
such	NULL
as	NULL
Oct2A	NULL
in	NULL
B	NULL
cells	NULL
}	NULL
.	NULL

'The	NULL
observation	NULL
that	NULL
both	NULL
HMG	NULL
I/Y	NULL
and	NULL
Oct-2	NULL
interact	NULL
with	NULL
the	NULL
DRA	NULL
octamer	NULL
prompted	NULL
us	NULL
to	NULL
investigate	NULL
possible	NULL
interactions	NULL
between	NULL
these	NULL
proteins	NULL
.	NULL

Cotransfection	NULL
of	NULL
an	NULL
HMG	NULL
I/Y	NULL
expression	NULL
vector	NULL
with	NULL
either	NULL
Oct-1	NULL
or	NULL
Oct-2A	NULL
expression	NULL
vectors	NULL
into	NULL
the	NULL
class	NULL
II-negative	NULL
cell	NULL
line	NULL
Jurkat	NULL
indicated	NULL
that	NULL
HMG	NULL
I/Y	NULL
can	NULL
selectively	NULL
facilitate	NULL
the	NULL
ability	NULL
of	NULL
Oct-2A	NULL
to	NULL
transactivate	NULL
the	NULL
DRA	NULL
promoter	NULL
.	NULL

Furthermore	NULL
,	NULL
HMG	NULL
I/Y	NULL
selectively	NULL
facilitates	NULL
the	NULL
binding	NULL
of	NULL
Oct-2A	NULL
,	NULL
but	NULL
not	NULL
Oct-1	NULL
,	NULL
to	NULL
the	NULL
octamer	NULL
element	NULL
in	NULL
EMSAs	NULL
.	NULL

A	NULL
ternary	NULL
complex	NULL
of	NULL
Oct-protein/HMG	NULL
I/octamer	NULL
was	NULL
not	NULL
apparent	NULL
in	NULL
our	NULL
gel	NULL
shift	NULL
assays	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
HMG	NULL
I/Y	NULL
did	NULL
not	NULL
significantly	NULL
alter	NULL
the	NULL
migration	NULL
of	NULL
the	NULL
Oct-2	NULL
or	NULL
Oct-1	NULL
complexes	NULL
,	NULL
and	NULL
the	NULL
inclusion	NULL
of	NULL
antibody	NULL
to	NULL
HMG	NULL
I/Y	NULL
in	NULL
the	NULL
reactions	NULL
did	NULL
not	NULL
result	NULL
in	NULL
a	NULL
significant	NULL
change	NULL
in	NULL
mobility	NULL
of	NULL
the	NULL
complex	NULL
(	NULL
Figs	NULL
.	NULL

7	NULL
A	NULL
,	NULL
8	NULL
A	NULL
,	NULL
and	NULL
8	NULL
B	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
small	NULL
size	NULL
of	NULL
HMG	NULL
I/Y	NULL
or	NULL
may	NULL
be	NULL
due	NULL
to	NULL
instability	NULL
of	NULL
the	NULL
HMG	NULL
497	NULL
Abdulkadir	NULL
et	NULL
al	NULL
.	NULL

I/Y	NULL
containing	NULL
complex	NULL
under	NULL
the	NULL
EMSA	NULL
conditions	NULL
.	NULL

There	NULL
is	NULL
indeed	NULL
precedence	NULL
for	NULL
proteins	NULL
that	NULL
enhance	NULL
the	NULL
binding	NULL
of	NULL
sequence-specific	NULL
transcription	NULL
factors	NULL
to	NULL
DNA	NULL
without	NULL
being	NULL
retained	NULL
in	NULL
the	NULL
complex	NULL
during	NULL
nondenaturing	NULL
elec-trophoresis	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
Phox	NULL
1	NULL
enhanced	NULL
the	NULL
binding	NULL
of	NULL
serum	NULL
response	NULL
factor	NULL
to	NULL
DNA	NULL
without	NULL
altering	NULL
the	NULL
mobility	NULL
of	NULL
SRF-DNA	NULL
complexes	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Like	NULL
the	NULL
DNA-bending	NULL
protein	NULL
,	NULL
HMG-1	NULL
facilitated	NULL
the	NULL
binding	NULL
of	NULL
progesterone	NULL
receptor	NULL
to	NULL
its	NULL
target	NULL
DNA	NULL
without	NULL
being	NULL
retained	NULL
in	NULL
the	NULL
complex	NULL
(	NULL
54	NULL
)	NULL
.	NULL

HMG	NULL
I	NULL
and	NULL
its	NULL
alternatively	NULL
spliced	NULL
variant	NULL
HMG	NULL
Y	NULL
(	NULL
which	NULL
lacks	NULL
an	NULL
internal	NULL
stretch	NULL
of	NULL
11	NULL
amino	NULL
acids	NULL
)	NULL
,	NULL
are	NULL
well-characterized	NULL
chromosomal	NULL
nonhistone	NULL
proteins	NULL
preferentially	NULL
associated	NULL
with	NULL
active	NULL
chromatin	NULL
.	NULL

These	NULL
basic	NULL
,	NULL
low	NULL
molecular	NULL
weight	NULL
proteins	NULL
are	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
rapidly	NULL
dividing	NULL
,	NULL
undifferentiated	NULL
,	NULL
or	NULL
neoplastically	NULL
transformed	NULL
cells	NULL
.	NULL

A	NULL
role	NULL
for	NULL
HMG	NULL
I/Y	NULL
has	NULL
been	NULL
invoked	NULL
in	NULL
the	NULL
positioning	NULL
of	NULL
nucleosomes	NULL
on	NULL
DNA	NULL
(	NULL
55	NULL
)	NULL
;	NULL
in	NULL
the	NULL
replication	NULL
of	NULL
ribosomal	NULL
DNA	NULL
(	NULL
56	NULL
)	NULL
;	NULL
in	NULL
the	NULL
stimulation	NULL
of	NULL
transcription	NULL
of	NULL
ribosomal	NULL
RNA	NULL
(	NULL
57	NULL
)	NULL
and	NULL
lymphotoxin	NULL
genes	NULL
(	NULL
58	NULL
)	NULL
;	NULL
in	NULL
the	NULL
virus	NULL
induction	NULL
of	NULL
the	NULL
IFN-B	NULL
gene	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
;	NULL
and	NULL
in	NULL
the	NULL
displacement	NULL
of	NULL
histone	NULL
H1	NULL
from	NULL
scaffold	NULL
attachment	NULL
regions	NULL
(	NULL
59	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
HMG	NULL
I/Y	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
repression	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
,	NULL
a	NULL
finding	NULL
which	NULL
is	NULL
in	NULL
sharp	NULL
contrast	NULL
to	NULL
its	NULL
usual	NULL
stimulatory	NULL
effect	NULL
on	NULL
transcription	NULL
(	NULL
60	NULL
)	NULL
.	NULL

It	NULL
thus	NULL
appears	NULL
that	NULL
HMG	NULL
I/	NULL
Y	NULL
,	NULL
as	NULL
a	NULL
structural	NULL
component	NULL
of	NULL
active	NULL
chromatin	NULL
,	NULL
may	NULL
serve	NULL
divergent	NULL
functions	NULL
.	NULL

The	NULL
mechanisms	NULL
by	NULL
which	NULL
HMG	NULL
I/	NULL
Y	NULL
can	NULL
influence	NULL
transcription	NULL
are	NULL
still	NULL
incompletely	NULL
understood	NULL
.	NULL

HMG	NULL
I/Y	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
facilitate	NULL
the	NULL
binding	NULL
of	NULL
certain	NULL
transcription	NULL
factors	NULL
to	NULL
DNA	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

This	NULL
feature	NULL
of	NULL
HMG	NULL
I/Y	NULL
could	NULL
be	NULL
explained	NULL
by	NULL
at	NULL
least	NULL
two	NULL
non-mutually	NULL
exclusive	NULL
mechanisms	NULL
.	NULL

First	NULL
,	NULL
since	NULL
HMG	NULL
I/Y	NULL
can	NULL
bend	NULL
DNA	NULL
,	NULL
this	NULL
could	NULL
promote	NULL
factor-binding	NULL
by	NULL
reducing	NULL
the	NULL
free	NULL
energy	NULL
of	NULL
association	NULL
of	NULL
an	NULL
activator	NULL
with	NULL
its	NULL
binding	NULL
site	NULL
.	NULL

Second	NULL
,	NULL
direct	NULL
protein-protein	NULL
interactions	NULL
between	NULL
HMG	NULL
I/Y	NULL
and	NULL
transcription	NULL
factors	NULL
may	NULL
promote	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
latter	NULL
to	NULL
their	NULL
cognate	NULL
DNA-binding	NULL
sites	NULL
.	NULL

Our	NULL
studies	NULL
show	NULL
that	NULL
HMG	NULL
I/Y	NULL
can	NULL
discriminate	NULL
between	NULL
octamer-binding	NULL
pro-teins	NULL
,	NULL
selectively	NULL
facilitating	NULL
the	NULL
binding	NULL
of	NULL
Oct-2A	NULL
but	NULL
not	NULL
Oct-1	NULL
to	NULL
the	NULL
octamer	NULL
site	NULL
.	NULL

These	NULL
observations	NULL
lead	NULL
us	NULL
to	NULL
hypothesize	NULL
that	NULL
direct	NULL
protein-protein	NULL
interactions	NULL
between	NULL
HMG	NULL
I/Y	NULL
and	NULL
the	NULL
Oct	NULL
proteins	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
determining	NULL
the	NULL
ability	NULL
of	NULL
HMG	NULL
I/Y	NULL
to	NULL
facilitate	NULL
binding	NULL
of	NULL
Oct-2A	NULL
to	NULL
the	NULL
octamer	NULL
element	NULL
.	NULL

Indeed	NULL
,	NULL
ongoing	NULL
experiments	NULL
in	NULL
our	NULL
lab	NULL
indicate	NULL
that	NULL
HMG	NULL
I/Y	NULL
can	NULL
interact	NULL
with	NULL
Oct-2A	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
(	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

Our	NULL
studies	NULL
suggest	NULL
a	NULL
requirement	NULL
for	NULL
HMG	NULL
I/Y	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
DRA	NULL
gene	NULL
by	NULL
IFN-y	NULL
.	NULL

The	NULL
mechanisms	NULL
by	NULL
which	NULL
HMG	NULL
I/Y	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
IFN-y	NULL
induction	NULL
are	NULL
not	NULL
entirely	NULL
clear	NULL
at	NULL
present	NULL
.	NULL

However	NULL
,	NULL
treatment	NULL
of	NULL
Hela	NULL
cells	NULL
with	NULL
IFN-	NULL
>	NULL
induces	NULL
the	NULL
binding	NULL
of	NULL
a	NULL
complex	NULL
that	NULL
contains	NULL
HMG	NULL
I/Y	NULL
to	NULL
the	NULL
DRA	NULL
octamer	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
D	NULL
)	NULL
.	NULL

We	NULL
hypothesize	NULL
that	NULL
IFN-y	NULL
induces	NULL
posttranslational	NULL
modifications	NULL
in	NULL
HMG	NULL
I/Y	NULL
that	NULL
increase	NULL
its	NULL
affinity	NULL
for	NULL
the	NULL
octamer	NULL
element	NULL
.	NULL

This	NULL
is	NULL
reminiscent	NULL
of	NULL
what	NULL
has	NULL
been	NULL
observed	NULL
with	NULL
the	NULL
human	NULL
gene	NULL
,	NULL
where	NULL
viral	NULL
induction	NULL
of	NULL
gene	NULL
expression	NULL
results	NULL
in	NULL
the	NULL
de	NULL
novo	NULL
binding	NULL
of	NULL
protein	NULL
complexes	NULL
to	NULL
the	NULL
promoter	NULL
which	NULL
contain	NULL
HMG	NULL
I/Y	NULL
(	NULL
44	NULL
)	NULL
.	NULL

A	NULL
requirement	NULL
for	NULL
posttranslational	NULL
modification	NULL
of	NULL
HMG	NULL
I/Y	NULL
for	NULL
its	NULL
participation	NULL
in	NULL
gene	NULL
activation	NULL
would	NULL
perhaps	NULL
help	NULL
explain	NULL
the	NULL
efficacy	NULL
of	NULL
antisense	NULL
HMG	NULL
I/Y	NULL
RNA	NULL
in	NULL
inhibiting	NULL
the	NULL
induction	NULL
of	NULL
these	NULL
two	NULL
genes	NULL
.	NULL

During	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
these	NULL
experiments	NULL
we	NULL
were	NULL
surprised	NULL
that	NULL
antisense	NULL
HMG	NULL
I/Y	NULL
RNA	NULL
was	NULL
an	NULL
effective	NULL
reagent	NULL
in	NULL
assessing	NULL
the	NULL
role	NULL
of	NULL
HMG	NULL
I/Y	NULL
in	NULL
HLA-DRA	NULL
gene	NULL
transcription	NULL
in	NULL
view	NULL
of	NULL
the	NULL
high	NULL
abundance	NULL
of	NULL
both	NULL
HMG	NULL
I/Y	NULL
RNA	NULL
and	NULL
protein	NULL
in	NULL
practically	NULL
all	NULL
mammalian	NULL
cells	NULL
.	NULL

We	NULL
hypothesize	NULL
that	NULL
much	NULL
of	NULL
the	NULL
HMG	NULL
I/Y	NULL
found	NULL
in	NULL
the	NULL
nucleus	NULL
is	NULL
in	NULL
an	NULL
inactive	NULL
form	NULL
,	NULL
and	NULL
that	NULL
an	NULL
extracellular	NULL
signal	NULL
such	NULL
as	NULL
IFN-y	NULL
might	NULL
posttranslationally	NULL
modify	NULL
newly	NULL
synthesized	NULL
HMG	NULL
I/Y	NULL
to	NULL
an	NULL
active	NULL
form	NULL
.	NULL

This	NULL
modified	NULL
HMG	NULL
I/Y	NULL
would	NULL
be	NULL
``	NULL
active	NULL
``	NULL
because	NULL
it	NULL
(	NULL
a	NULL
)	NULL
binds	NULL
with	NULL
higher	NULL
affinity	NULL
to	NULL
DNA	NULL
(	NULL
as	NULL
our	NULL
data	NULL
suggest	NULL
)	NULL
,	NULL
and/or	NULL
(	NULL
5	NULL
)	NULL
promotes	NULL
protein-protein	NULL
interactions	NULL
more	NULL
effectively	NULL
than	NULL
unmodified	NULL
HMG	NULL
I/	NULL
Y	NULL
.	NULL

These	NULL
possibilities	NULL
are	NULL
under	NULL
active	NULL
investigation	NULL
in	NULL
our	NULL
laboratory	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
in	NULL
this	NULL
study	NULL
indicate	NULL
that	NULL
distinct	NULL
(	NULL
but	NULL
largely	NULL
overlapping	NULL
)	NULL
sets	NULL
of	NULL
transcription	NULL
factors	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
DRA	NULL
expression	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

Class	NULL
II-negative	NULL
cell	NULL
lines	NULL
,	NULL
such	NULL
as	NULL
Hela	NULL
and	NULL
Jurkat	NULL
,	NULL
while	NULL
containing	NULL
most	NULL
of	NULL
the	NULL
DNA-binding	NULL
proteins	NULL
known	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
promoter	NULL
,	NULL
do	NULL
not	NULL
have	NULL
an	NULL
active	NULL
transcription	NULL
complex	NULL
assembled	NULL
on	NULL
the	NULL
promoter	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
in	NULL
vivo	NULL
footprinting	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Induction	NULL
with	NULL
IFN-	NULL
>	NULL
y	NULL
leads	NULL
to	NULL
the	NULL
assembly	NULL
of	NULL
a	NULL
transcription	NULL
complex	NULL
on	NULL
the	NULL
promoter	NULL
(	NULL
40	NULL
)	NULL
.	NULL

This	NULL
transition	NULL
could	NULL
depend	NULL
on	NULL
the	NULL
de	NULL
novo	NULL
synthesis	NULL
or	NULL
modification	NULL
of	NULL
critical	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
(	NULL
which	NULL
may	NULL
or	NULL
may	NULL
not	NULL
interact	NULL
with	NULL
DNA	NULL
directly	NULL
)	NULL
that	NULL
are	NULL
critical	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
functional	NULL
transcription	NULL
complex	NULL
.	NULL

Our	NULL
findings	NULL
suggest	NULL
that	NULL
HMG	NULL
I/Y	NULL
likely	NULL
plays	NULL
such	NULL
a	NULL
role	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
DRA	NULL
gene	NULL
by	NULL
IFN-y	NULL
.	NULL

In	NULL
Hela	NULL
cells	NULL
induced	NULL
with	NULL
IFN-y	NULL
,	NULL
HMG	NULL
I/Y	NULL
appears	NULL
to	NULL
function	NULL
in	NULL
DRA	NULL
transcription	NULL
via	NULL
an	NULL
Oct-2-independent	NULL
pathway	NULL
.	NULL

Mutations	NULL
in	NULL
the	NULL
octamer	NULL
element	NULL
have	NULL
modest	NULL
effects	NULL
on	NULL
the	NULL
inducibility	NULL
of	NULL
the	NULL
DRA	NULL
promoter	NULL
,	NULL
while	NULL
severely	NULL
impairing	NULL
constitutive	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
after	NULL
induction	NULL
of	NULL
Hela	NULL
cells	NULL
with	NULL
IFN-y	NULL
,	NULL
we	NULL
found	NULL
no	NULL
evidence	NULL
of	NULL
de	NULL
novo	NULL
Oct-2	NULL
synthesis	NULL
using	NULL
gel-shift	NULL
assays	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IFN-y	NULL
treatment	NULL
enhances	NULL
the	NULL
binding	NULL
of	NULL
HMG	NULL
I/Y	NULL
to	NULL
the	NULL
octamer	NULL
element	NULL
.	NULL

The	NULL
modest	NULL
effect	NULL
of	NULL
the	NULL
octamer	NULL
mutation	NULL
on	NULL
IFN-y	NULL
inducibility	NULL
might	NULL
be	NULL
due	NULL
to	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
mutation	NULL
on	NULL
HMG	NULL
I/	NULL
Y	NULL
binding	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
double	NULL
mutations	NULL
in	NULL
the	NULL
octamer	NULL
and	NULL
the	NULL
D	NULL
box	NULL
elements	NULL
result	NULL
in	NULL
a	NULL
profound	NULL
reduction	NULL
in	NULL
IFN-y	NULL
inducibility	NULL
of	NULL
the	NULL
promoter	NULL
suggests	NULL
that	NULL
at	NULL
least	NULL
one	NULL
HMG	NULL
I/Y	NULL
molecule	NULL
bound	NULL
to	NULL
either	NULL
of	NULL
these	NULL
sites	NULL
is	NULL
required	NULL
for	NULL
induction	NULL
,	NULL
with	NULL
occupancy	NULL
of	NULL
both	NULL
sites	NULL
allowing	NULL
full	NULL
activation	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

Apart	NULL
from	NULL
the	NULL
mechanisms	NULL
described	NULL
above	NULL
,	NULL
HMG	NULL
I/Y	NULL
may	NULL
also	NULL
facilitate	NULL
interactions	NULL
between	NULL
DNA-bound	NULL
factors	NULL
and	NULL
adapter	NULL
proteins	NULL
(	NULL
such	NULL
as	NULL
the	NULL
recently	NULL
described	NULL
class	NULL
II	NULL
activator	NULL
,	NULL
CIITA	NULL
;	NULL
61	NULL
)	NULL
,	NULL
or	NULL
might	NULL
also	NULL
participate	NULL
at	NULL
a	NULL
step	NULL
before	NULL
transcription	NULL
complex	NULL
assembly	NULL
(	NULL
such	NULL
as	NULL
alteration	NULL
of	NULL
chro-matin	NULL
structure	NULL
)	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
the	NULL
data	NULL
presented	NULL
in	NULL
this	NULL
paper	NULL
indicate	NULL
that	NULL
the	NULL
HMG	NULL
I/Y	NULL
protein	NULL
and	NULL
the	NULL
Oct-2A	NULL
transcriptional	NULL
activator	NULL
are	NULL
essential	NULL
proteins	NULL
for	NULL
DRA	NULL
transcription	NULL
.	NULL

Distinct	NULL
sets	NULL
of	NULL
transcription	NULL
complexes	NULL
seem	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
DRA	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
induced	NULL
Hela	NULL
cells	NULL
,	NULL
and	NULL
HMG	NULL
I/Y	NULL
appears	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
both	NULL
situations	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
Oct2A	NULL
to	NULL
the	NULL
list	NULL
of	NULL
transcriptional	NULL
activators	NULL
facilitated	NULL
by	NULL
HMG	NULL
I/Y	NULL
further	NULL
underscores	NULL
the	NULL
notion	NULL
that	NULL
HMG	NULL
I/Y	NULL
plays	NULL
a	NULL
general	NULL
and	NULL
critical	NULL
role	NULL
in	NULL
transcription	NULL
complex	NULL
assembly	NULL
.	NULL

We	NULL
thank	NULL
M.	NULL
Tanaka	NULL
and	NULL
W.	NULL
Herr	NULL
for	NULL
the	NULL
pBS-Oct-1	NULL
plasmid	NULL
and	NULL
the	NULL
recombinant	NULL
Oct-2	NULL
protein	NULL
.	NULL

We	NULL
thank	NULL
members	NULL
of	NULL
the	NULL
Ono	NULL
Lab	NULL
and	NULL
Gary	NULL
Ketner	NULL
for	NULL
helpful	NULL
comments	NULL
and	NULL
discussion	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
S.	NULL
J.	NULL
Ono	NULL
,	NULL
T.	NULL
Maniatis	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Strominger	NULL
)	NULL
,	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
(	NULL
S.	NULL
J.	NULL
Ono	NULL
and	NULL
S.	NULL
A.	NULL
Abdulkadir	NULL
)	NULL
,	NULL
the	NULL
American	NULL
Diabetes	NULL
Association	NULL
(	NULL
career	NULL
development	NULL
award	NULL
)	NULL
(	NULL
S.	NULL
J.	NULL
Ono	NULL
)	NULL
,	NULL
the	NULL
Arthritis	NULL
Foundation	NULL
(	NULL
Investigator	NULL
award	NULL
)	NULL
(	NULL
S.	NULL
J.	NULL
Ono	NULL
)	NULL
,	NULL
and	NULL
Hoffmann-LaRoche	NULL
Pharmaceutical	NULL
Corp.	NULL
(	NULL
S.	NULL
J.	NULL
Ono	NULL
)	NULL
.	NULL

S.	NULL
A.	NULL
Abdulkadir	NULL
is	NULL
a	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
postdoctoral	NULL
fellow	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Dr.	NULL
S.	NULL
J.	NULL
Ono	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Lucille	NULL
P.	NULL
Markey	NULL
Graduate	NULL
Program	NULL
in	NULL
Cellular/	NULL
Molecular	NULL
Medicine	NULL
,	NULL
The	NULL
Johns	NULL
Hopkins	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
5501	NULL
Hopkins	NULL
Bayview	NULL
Circle	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
21224	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
3	NULL
August	NULL
1994	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
6	NULL
March	NULL
1995	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Kappes	NULL
,	NULL
DJ	NULL
.	NULL

,	NULL
and	NULL
J.L	NULL
.	NULL

Strominger	NULL
.	NULL

1988	NULL
.	NULL

Human	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
complex	NULL
genes	NULL
and	NULL
proteins	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Bio-chem	NULL
.	NULL

57:991-1028	NULL
.	NULL

2	NULL
.	NULL

Kaufman	NULL
,	NULL
J.F	NULL
.	NULL

,	NULL
C.	NULL
Auffray	NULL
,	NULL
A.J	NULL
.	NULL

Korman	NULL
,	NULL
D.A	NULL
.	NULL

Shakelford	NULL
,	NULL
and	NULL
J.L	NULL
.	NULL

Strominger	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
class	NULL
II	NULL
molecules	NULL
of	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
major	NULL
histocompatibility	NULL
complex	NULL
.	NULL

Cell	NULL
.	NULL

36:1-13	NULL
.	NULL

3	NULL
.	NULL

Symington	NULL
,	NULL
FW	NULL
.	NULL

,	NULL
F.	NULL
Levine	NULL
,	NULL
M.	NULL
Braun	NULL
,	NULL
SL	NULL
.	NULL

Brown	NULL
,	NULL
H.	NULL
A.	NULL
Er-lich	NULL
,	NULL
and	NULL
B.	NULL
Torok-Storb	NULL
.	NULL

1985	NULL
.	NULL

Differential	NULL
Ia	NULL
antigen	NULL
expres-	NULL
498	NULL
Roles	NULL
of	NULL
High	NULL
Mobility	NULL
Group	NULL
Protein	NULL
I/Y	NULL
and	NULL
Oct-2	NULL
in	NULL
HLA-DRA	NULL
Transcription	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21.	NULL
sion	NULL
by	NULL
autologous	NULL
human	NULL
erythroid	NULL
and	NULL
B	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

135:1062-1073.	NULL
.	NULL

Lucey	NULL
,	NULL
D.R	NULL
.	NULL

,	NULL
A.	NULL
NicholsonWeller	NULL
,	NULL
and	NULL
P.F	NULL
.	NULL

Weller	NULL
.	NULL

1989	NULL
.	NULL

Ma	NULL
ture	NULL
human	NULL
eosinophils	NULL
have	NULL
the	NULL
capacity	NULL
to	NULL
express	NULL
HLA-DR.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

86:1348-1351.	NULL
.	NULL

Ono	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
V.	NULL
Bazil	NULL
,	NULL
M.	NULL
Sugawara	NULL
,	NULL
and	NULL
J.L	NULL
.	NULL

Strominger	NULL
.	NULL

1991	NULL
.	NULL

An	NULL
isotype-specific	NULL
trans-acting	NULL
factor	NULL
is	NULL
defective	NULL
in	NULL
a	NULL
mutant	NULL
B	NULL
cell	NULL
line	NULL
that	NULL
expresses	NULL
HLA-DQ	NULL
,	NULL
but	NULL
not	NULL
-DR	NULL
or	NULL
-DP	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

173:629-637.	NULL
.	NULL

Ting	NULL
,	NULL
J.P.-Y	NULL
.	NULL

1993	NULL
.	NULL

Current	NULL
concepts	NULL
in	NULL
DRA	NULL
gene	NULL
regula-	NULL
tion	NULL
.	NULL

Immunol	NULL
.	NULL

Res	NULL
.	NULL

12:65-77.	NULL
.	NULL

King	NULL
,	NULL
D.P	NULL
.	NULL

,	NULL
and	NULL
PP	NULL
.	NULL

Jones	NULL
.	NULL

1983	NULL
.	NULL

Induction	NULL
of	NULL
Ia	NULL
and	NULL
H-2	NULL
an	NULL
tigens	NULL
in	NULL
a	NULL
macrophage	NULL
cell	NULL
line	NULL
by	NULL
immune	NULL
interferon	NULL
.	NULL

J.	NULL
Im-	NULL
munol	NULL
.	NULL

131:315-318.	NULL
.	NULL

Pober	NULL
,	NULL
J.S	NULL
.	NULL

,	NULL
T.	NULL
Collins	NULL
,	NULL
M.A	NULL
.	NULL

Gimbrone	NULL
,	NULL
R.S	NULL
.	NULL

Cotran	NULL
,	NULL
J.D	NULL
.	NULL

Gitlin	NULL
,	NULL
W.	NULL
Fiers	NULL
,	NULL
C.	NULL
Clayberger	NULL
,	NULL
A.M.	NULL
Krensky	NULL
,	NULL
S.J	NULL
.	NULL

Burakoff	NULL
,	NULL
and	NULL
C.S	NULL
.	NULL

Reiss	NULL
.	NULL

1983	NULL
.	NULL

Lymphocytes	NULL
recognize	NULL
human	NULL
vascular	NULL
endothelial	NULL
and	NULL
dermal	NULL
fibroblast	NULL
Ia	NULL
antigens	NULL
induced	NULL
by	NULL
recombinant	NULL
immune	NULL
interferon	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

305:726-729.	NULL
.	NULL

Pujol-Borrell	NULL
,	NULL
R.	NULL
,	NULL
I.	NULL
Todd	NULL
,	NULL
M.	NULL
Doshi	NULL
,	NULL
G.F.	NULL
Bottazzo	NULL
,	NULL
R.	NULL
Sutton	NULL
,	NULL
GR	NULL
.	NULL

Adolf	NULL
,	NULL
and	NULL
M.	NULL
Feldman	NULL
.	NULL

1987	NULL
.	NULL

HLA	NULL
class	NULL
II	NULL
induction	NULL
in	NULL
human	NULL
islet	NULL
cells	NULL
by	NULL
interferon-y	NULL
plus	NULL
tumor	NULL
necrosis	NULL
factor	NULL
or	NULL
lymphotoxin	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

326:304-306	NULL
.	NULL

Ono	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
I.-C.	NULL
Badia	NULL
,	NULL
E.	NULL
Colle	NULL
,	NULL
RD	NULL
.	NULL

Guttman	NULL
,	NULL
T.A	NULL
.	NULL

See-mayer	NULL
,	NULL
and	NULL
A.	NULL
Fuks	NULL
.	NULL

1988	NULL
.	NULL

Enhanced	NULL
MHC	NULL
class	NULL
I	NULL
heavy-chain	NULL
gene	NULL
expression	NULL
in	NULL
pancreatic	NULL
islets	NULL
.	NULL

Diabetes	NULL
.	NULL

37:1411-1418.	NULL
dePreval	NULL
,	NULL
C.	NULL
,	NULL
B.	NULL
Lisowska-Grospierre	NULL
,	NULL
M.	NULL
Loche	NULL
,	NULL
C.	NULL
Griscelli	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1985	NULL
.	NULL

A	NULL
trans-acting	NULL
class	NULL
II	NULL
regulatory	NULL
gene	NULL
un-linked	NULL
to	NULL
the	NULL
MHC	NULL
controls	NULL
expression	NULL
of	NULL
HL	NULL
A	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

318:291-293	NULL
.	NULL

Hume	NULL
,	NULL
C.R	NULL
.	NULL

,	NULL
and	NULL
J.S	NULL
.	NULL

Lee	NULL
.	NULL

1989	NULL
.	NULL

Congenital	NULL
immunodeficien-cies	NULL
associated	NULL
with	NULL
absence	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
antigens	NULL
on	NULL
lymphocytes	NULL
result	NULL
from	NULL
distinct	NULL
mutations	NULL
in	NULL
trans-acting	NULL
factors	NULL
.	NULL

Hum	NULL
.	NULL

Immunol	NULL
.	NULL

26:288-309	NULL
.	NULL

Glimcher	NULL
,	NULL
L.H	NULL
.	NULL

,	NULL
and	NULL
C.J	NULL
.	NULL

Kara	NULL
.	NULL

1992	NULL
.	NULL

Sequences	NULL
and	NULL
factors	NULL
:	NULL
a	NULL
guide	NULL
to	NULL
MHC	NULL
class	NULL
II	NULL
transcription	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

10:13-49	NULL
.	NULL

Sherman	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
PV	NULL
.	NULL

Basta	NULL
,	NULL
and	NULL
J.-PY	NULL
.	NULL

Ting	NULL
.	NULL

1987	NULL
.	NULL

Upstream	NULL
DNA	NULL
sequences	NULL
required	NULL
for	NULL
tissue-specific	NULL
expression	NULL
of	NULL
the	NULL
HLA-DRa	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

84:4245-4258	NULL
.	NULL

Miwa	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
Doyle	NULL
,	NULL
and	NULL
J.L	NULL
.	NULL

Strominger	NULL
.	NULL

1987	NULL
.	NULL

Sequence-specific	NULL
interactions	NULL
of	NULL
nuclear	NULL
factors	NULL
with	NULL
conserved	NULL
sequences	NULL
of	NULL
human	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
complex	NULL
genes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

85:3075-3079	NULL
.	NULL

Tsang	NULL
,	NULL
SY	NULL
.	NULL

,	NULL
M.	NULL
Nakanishi	NULL
,	NULL
and	NULL
B.M	NULL
.	NULL

Peterlin	NULL
.	NULL

1990	NULL
.	NULL

Mutational	NULL
analysis	NULL
of	NULL
the	NULL
DRA	NULL
promoter	NULL
:	NULL
cis-acting	NULL
sequences	NULL
and	NULL
transacting	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:1361-1367	NULL
.	NULL

Vilen	NULL
,	NULL
BJ	NULL
.	NULL

,	NULL
J.P.	NULL
Cogswell	NULL
,	NULL
and	NULL
J.-PY	NULL
.	NULL

Ting	NULL
.	NULL

1991	NULL
.	NULL

Stereospecific	NULL
alignment	NULL
of	NULL
the	NULL
X	NULL
and	NULL
Y	NULL
elements	NULL
is	NULL
required	NULL
for	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
DRA	NULL
promoter	NULL
function	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:2406-2415	NULL
.	NULL

Didier	NULL
,	NULL
D.K	NULL
.	NULL

,	NULL
J.	NULL
Schiffenbauer	NULL
,	NULL
S.L	NULL
.	NULL

Woulfe	NULL
,	NULL
M.	NULL
Zacheis	NULL
,	NULL
and	NULL
B.D	NULL
.	NULL

Schwartz	NULL
.	NULL

1988	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
cDNA	NULL
encoding	NULL
a	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
Y	NULL
box	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

85:7322-7326	NULL
.	NULL

Hooft	NULL
van	NULL
Huijsduijnen	NULL
,	NULL
R.	NULL
,	NULL
XY	NULL
.	NULL

Li	NULL
,	NULL
D.	NULL
Black	NULL
,	NULL
H.	NULL
Malthes	NULL
,	NULL
C.	NULL
Benoist	NULL
,	NULL
and	NULL
D.	NULL
Mathis	NULL
.	NULL

1990	NULL
.	NULL

Co-evolution	NULL
from	NULL
yeast	NULL
to	NULL
mouse	NULL
:	NULL
cDNA	NULL
clones	NULL
of	NULL
the	NULL
two	NULL
NFY	NULL
(	NULL
CP-1/CBF	NULL
)	NULL
subunits	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

9:3119-3127	NULL
.	NULL

Reith	NULL
,	NULL
W.	NULL
,	NULL
C.-A	NULL
.	NULL

Siegrist	NULL
,	NULL
B.	NULL
Durand	NULL
,	NULL
E.	NULL
Barras	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
promoter	NULL
requires	NULL
cooperative	NULL
binding	NULL
between	NULL
factors	NULL
RFX	NULL
and	NULL
NFY	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

91:554-558	NULL
.	NULL

Reith	NULL
,	NULL
W.	NULL
,	NULL
E.	NULL
Barras	NULL
,	NULL
S.	NULL
Satola	NULL
,	NULL
M.	NULL
Kobt	NULL
,	NULL
D.	NULL
Reinhart	NULL
,	NULL
C.H	NULL
.	NULL

499	NULL
Abdulkadir	NULL
et	NULL
al	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

Sanchez	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1989	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
promoter	NULL
binding	NULL
protein	NULL
affected	NULL
in	NULL
a	NULL
hereditary	NULL
defect	NULL
in	NULL
class	NULL
II	NULL
gene	NULL
regulation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

86:4200-4204	NULL
.	NULL

Reith	NULL
,	NULL
W.	NULL
,	NULL
C.H	NULL
.	NULL

Sanchez	NULL
,	NULL
M.	NULL
Kobr	NULL
,	NULL
P.	NULL
Silacci	NULL
,	NULL
C.	NULL
Berte	NULL
,	NULL
E.	NULL
Barras	NULL
,	NULL
S.	NULL
Fey	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1990	NULL
.	NULL

MHC	NULL
class	NULL
II	NULL
regulatory	NULL
factor	NULL
RF-X	NULL
has	NULL
a	NULL
novel	NULL
DNA-binding	NULL
domain	NULL
and	NULL
a	NULL
functionally	NULL
independent	NULL
dimerization	NULL
domain	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
4:1528-1540	NULL
.	NULL

Song	NULL
,	NULL
Z.	NULL
,	NULL
S.	NULL
Krishna	NULL
,	NULL
D.	NULL
Thanos	NULL
,	NULL
J.L	NULL
.	NULL

Strominger	NULL
,	NULL
and	NULL
S.J	NULL
.	NULL

Ono	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
novel	NULL
cysteine-rich	NULL
sequence-specific	NULL
DNA-binding	NULL
protein	NULL
interacts	NULL
with	NULL
the	NULL
conserved	NULL
X-box	NULL
motif	NULL
of	NULL
the	NULL
human	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
genes	NULL
via	NULL
a	NULL
repeated	NULL
Cys-His	NULL
domain	NULL
and	NULL
functions	NULL
as	NULL
a	NULL
transcriptional	NULL
repressor	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:1763-1774	NULL
;	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Boothby	NULL
,	NULL
MR.	NULL
,	NULL
and	NULL
Glimcher	NULL
,	NULL
L.H	NULL
.	NULL

1988	NULL
.	NULL

Distinct	NULL
cloned	NULL
class	NULL
II	NULL
MHC	NULL
DNA-binding	NULL
proteins	NULL
recognize	NULL
the	NULL
X	NULL
box	NULL
transcription	NULL
element	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

242:69-71	NULL
.	NULL

Peterlin	NULL
,	NULL
BM	NULL
.	NULL

,	NULL
and	NULL
G.	NULL
Andersson	NULL
.	NULL

1990	NULL
.	NULL

NF-X2	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
DRA	NULL
X2-box	NULL
is	NULL
activator	NULL
protein	NULL
1	NULL
:	NULL
expression	NULL
cloning	NULL
of	NULL
cjun	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

145:3456-3462	NULL
.	NULL

Ono	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
and	NULL
Z	NULL
.	NULL

Song	NULL
.	NULL

1995	NULL
.	NULL

Mapping	NULL
of	NULL
the	NULL
interaction	NULL
site	NULL
of	NULL
the	NULL
defective	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
class	NULL
II	NULL
MHC	NULL
mutant	NULL
cell	NULL
line	NULL
Clone-13	NULL
to	NULL
the	NULL
divergent	NULL
X2-box	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

In	NULL
press	NULL
.	NULL

Ono	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
V.	NULL
Bazil	NULL
,	NULL
B-Z	NULL
.	NULL

Levi	NULL
,	NULL
K.	NULL
Ozato	NULL
,	NULL
and	NULL
J.L	NULL
.	NULL

Strominger	NULL
.	NULL

1991	NULL
.	NULL

Transcription	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
human	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
complex	NULL
genes	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
nucleoprotein	NULL
complex	NULL
that	NULL
contains	NULL
c-fos	NULL
or	NULL
an	NULL
antigenically	NULL
related	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

88:4304-4308	NULL
.	NULL

Ono	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
H.-C.	NULL
Liou	NULL
,	NULL
R.	NULL
Davidon	NULL
,	NULL
J.L	NULL
.	NULL

Strominger	NULL
,	NULL
and	NULL
L.H	NULL
.	NULL

Glimcher	NULL
.	NULL

1991	NULL
.	NULL

Transient	NULL
expression	NULL
of	NULL
antisense	NULL
hXBP-1	NULL
RNA	NULL
inhibits	NULL
the	NULL
transcription	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
human	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
complex	NULL
genes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

88:4309-4312	NULL
.	NULL

Boss	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
and	NULL
J.L	NULL
.	NULL

Strominger	NULL
.	NULL

1986	NULL
.	NULL

Regulation	NULL
of	NULL
a	NULL
transfected	NULL
human	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
complex	NULL
gene	NULL
in	NULL
human	NULL
fibroblast	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

83:9139-9143	NULL
.	NULL

Servenius	NULL
,	NULL
B.	NULL
,	NULL
L.	NULL
Rask	NULL
,	NULL
and	NULL
P.A	NULL
.	NULL

Peterson	NULL
.	NULL

1987	NULL
.	NULL

Class	NULL
II	NULL
genes	NULL
of	NULL
the	NULL
human	NULL
major	NULL
histocompatibility	NULL
complex	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262:8759-8766	NULL
.	NULL

Tsang	NULL
,	NULL
SY	NULL
.	NULL

,	NULL
M.	NULL
Nakanishi	NULL
,	NULL
and	NULL
B.M	NULL
.	NULL

Peterlin	NULL
.	NULL

1988	NULL
.	NULL

B-cell-specific	NULL
and	NULL
interferon-y-inducible	NULL
regulation	NULL
of	NULL
the	NULL
HLA-DRa	NULL
«	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

85:8598-8602	NULL
.	NULL

Thanos	NULL
,	NULL
D.	NULL
,	NULL
G.	NULL
Mavrothalassitis	NULL
,	NULL
and	NULL
J.	NULL
Papamatheakis	NULL
.	NULL

1988	NULL
.	NULL

Multiple	NULL
regulatory	NULL
regions	NULL
of	NULL
the	NULL
5	NULL
side	NULL
of	NULL
the	NULL
mouse	NULL
Ea	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

$	NULL
5:3075-3079	NULL
.	NULL

Cogswell	NULL
,	NULL
J.P.	NULL
,	NULL
PV	NULL
.	NULL

Basta	NULL
,	NULL
and	NULL
J.P.-Y	NULL
.	NULL

Ting	NULL
.	NULL

1990	NULL
.	NULL

X-box	NULL
binding	NULL
proteins	NULL
positively	NULL
and	NULL
negatively	NULL
regulate	NULL
transcription	NULL
of	NULL
the	NULL
HLA-DRA	NULL
gene	NULL
through	NULL
interaction	NULL
with	NULL
discrete	NULL
upstream	NULL
W	NULL
and	NULL
V	NULL
elements	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

87:7703-7707	NULL
.	NULL

Dedrick	NULL
,	NULL
RL	NULL
.	NULL

,	NULL
and	NULL
P.P	NULL
.	NULL

Jones	NULL
.	NULL

1990	NULL
.	NULL

Sequence	NULL
elements	NULL
required	NULL
for	NULL
activity	NULL
of	NULL
a	NULL
murine	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
promoter	NULL
bind	NULL
common	NULL
and	NULL
cell	NULL
type-specific	NULL
nuclear	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:593-598	NULL
.	NULL

Sugawara	NULL
,	NULL
M.	NULL
,	NULL
P.D	NULL
.	NULL

Ponath	NULL
,	NULL
Z.	NULL
Yang	NULL
,	NULL
and	NULL
J.L	NULL
.	NULL

Strominger	NULL
.	NULL

1992	NULL
.	NULL

Interferon-y	NULL
response	NULL
region	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
class	NULL
II	NULL
MHC	NULL
gene	NULL
DPA	NULL
.	NULL

Hum	NULL
.	NULL

Immunol	NULL
.	NULL

35:1157-1164	NULL
.	NULL

Parslow	NULL
,	NULL
T.G	NULL
.	NULL

,	NULL
D.L	NULL
.	NULL

Blair	NULL
,	NULL
W.G	NULL
.	NULL

Murphy	NULL
,	NULL
and	NULL
D.K	NULL
.	NULL

Granner	NULL
.	NULL

1984	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
5	NULL
ends	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
:	NULL
a	NULL
novel	NULL
conserved	NULL
sequence	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

81:2650-2654.	NULL
.	NULL

Ephrussi	NULL
,	NULL
A.	NULL
,	NULL
G.M	NULL
.	NULL

Church	NULL
,	NULL
S.	NULL
Tonegawa	NULL
,	NULL
and	NULL
W.	NULL
Gilbert	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

1985	NULL
.	NULL

B	NULL
lineage-specific	NULL
interactions	NULL
of	NULL
an	NULL
immunoglobulin	NULL
enhancer	NULL
with	NULL
cellular	NULL
factors	NULL
in	NULL
vivo	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

227:134-140	NULL
.	NULL

Miwa	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
J.L	NULL
.	NULL

Strominger	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
gene	NULL
upstream	NULL
region	NULL
contains	NULL
an	NULL
immunoglobulin-like	NULL
octamer	NULL
motif	NULL
that	NULL
binds	NULL
cell-type	NULL
specific	NULL
unclear	NULL
factors	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15:8057-8067	NULL
.	NULL

Stimac	NULL
,	NULL
E.	NULL
,	NULL
S.	NULL
Lyons	NULL
,	NULL
and	NULL
D.	NULL
Pious	NULL
.	NULL

1988	NULL
.	NULL

Transcription	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
genes	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
B-cell-specific	NULL
octamer-binding	NULL
factor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:3734-3739	NULL
.	NULL

Wright	NULL
,	NULL
K.L	NULL
.	NULL

,	NULL
and	NULL
J.P.-Y	NULL
.	NULL

Ting	NULL
.	NULL

1992	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
analysis	NULL
of	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
:	NULL
cell-specific	NULL
interactions	NULL
at	NULL
the	NULL
octamer	NULL
site	NULL
and	NULL
upregulation	NULL
of	NULL
X	NULL
box	NULL
binding	NULL
proteins	NULL
by	NULL
interferon-y	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

89:7601-7605	NULL
.	NULL

Kara	NULL
,	NULL
C.J	NULL
.	NULL

,	NULL
and	NULL
LH	NULL
.	NULL

Glimcher	NULL
.	NULL

1991	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
genes	NULL
:	NULL
Bare	NULL
promoters	NULL
in	NULL
the	NULL
Bare	NULL
lymphocyte	NULL
syndrome	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

252:709-712	NULL
.	NULL

Sherman	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
PV	NULL
.	NULL

Basta	NULL
,	NULL
A.	NULL
Heguy	NULL
,	NULL
M.K	NULL
.	NULL

Wloch	NULL
,	NULL
R.G	NULL
.	NULL

Roeder	NULL
,	NULL
and	NULL
J.-PY	NULL
.	NULL

Ting	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
octamer	NULL
motif	NULL
is	NULL
a	NULL
B	NULL
lymphocyte-specific	NULL
regulatory	NULL
element	NULL
of	NULL
the	NULL
HLA-Drax	NULL
gene	NULL
promoter	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

86:6739-6743	NULL
.	NULL

Thanos	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
high	NULL
mobility	NULL
group	NULL
protein	NULL
HMG	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
is	NULL
required	NULL
for	NULL
NF-	NULL
«	NULL
-B-dependent	NULL
virus	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
IFN-beta	NULL
gene	NULL
.	NULL

Cell	NULL
.	NULL

71:777-789	NULL
.	NULL

Du	NULL
,	NULL
W.	NULL
,	NULL
D.	NULL
Thanos	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1993	NULL
.	NULL

Mechanisms	NULL
of	NULL
transcriptional	NULL
synergism	NULL
between	NULL
distinct	NULL
virus-inducible	NULL
enhancer	NULL
elements	NULL
.	NULL

Cell	NULL
.	NULL

74:887-898	NULL
.	NULL

Phares	NULL
,	NULL
W.	NULL
,	NULL
B.R	NULL
.	NULL

Franza	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
kappa	NULL
B	NULL
enhancer	NULL
motifs	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
and	NULL
simian	NULL
virus	NULL
40	NULL
recognize	NULL
different	NULL
binding	NULL
activities	NULL
in	NULL
human	NULL
Jurkat	NULL
and	NULL
H9	NULL
T	NULL
cells	NULL
:	NULL
evidence	NULL
for	NULL
NF-kappa	NULL
B-inde-pendent	NULL
activation	NULL
of	NULL
the	NULL
kappa	NULL
B	NULL
motif	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:7490-7498	NULL
.	NULL

Zeleznik-Le	NULL
,	NULL
N.	NULL
,	NULL
Y.	NULL
Itoh-Lindstrom	NULL
,	NULL
J.B.	NULL
Clarke	NULL
,	NULL
T.L	NULL
.	NULL

Moore	NULL
,	NULL
and	NULL
J.-P.Y	NULL
.	NULL

Ting	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
B	NULL
cell	NULL
specific	NULL
nuclear	NULL
factor	NULL
OTF-2	NULL
positively	NULL
regulates	NULL
transcription	NULL
of	NULL
the	NULL
human	NULL
class	NULL
II	NULL
transplantation	NULL
gene	NULL
DRA	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:7677-7682	NULL
.	NULL

Schereidet	NULL
,	NULL
C.	NULL
,	NULL
J.A	NULL
.	NULL

Cromlish	NULL
,	NULL
T.	NULL
Gerster	NULL
,	NULL
K.	NULL
Kawakami	NULL
,	NULL
C.-G.	NULL
Balmaceda	NULL
,	NULL
R.A.	NULL
Currie	NULL
,	NULL
and	NULL
R.G	NULL
.	NULL

Roeder	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
human	NULL
lymphoid-specific	NULL
transcription	NULL
factor	NULL
that	NULL
activates	NULL
immunoglobulin	NULL
genes	NULL
is	NULL
a	NULL
homeobox	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

336:551-557	NULL
.	NULL

Muller	NULL
,	NULL
M.M	NULL
.	NULL

,	NULL
S.	NULL
Ruppert	NULL
,	NULL
W.	NULL
Schaffner	NULL
,	NULL
and	NULL
P.	NULL
Matthias	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
cloned	NULL
octamer	NULL
transcription	NULL
factor	NULL
stimulates	NULL
transcription	NULL
from	NULL
lymphoid-specific	NULL
promoters	NULL
in	NULL
non-B	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

336:544-551	NULL
.	NULL

Eckner	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
ML	NULL
.	NULL

Birnsteil	NULL
.	NULL

1989	NULL
.	NULL

Cloning	NULL
of	NULL
cDNA	NULL
's	NULL
coding	NULL
for	NULL
human	NULL
HMG	NULL
I	NULL
and	NULL
HMG	NULL
Y	NULL
:	NULL
both	NULL
are	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
octamer	NULL
sequences	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:5947-5959	NULL
.	NULL

Matis	NULL
,	NULL
L.A.	NULL
,	NULL
L.	NULL
H.	NULL
Glimcher	NULL
,	NULL
W.E	NULL
.	NULL

Paul	NULL
,	NULL
and	NULL
R.H.	NULL
Schwarz	NULL
.	NULL

500	NULL
51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

1983	NULL
.	NULL

Magnitude	NULL
of	NULL
response	NULL
of	NULL
histocompatibility	NULL
restricted	NULL
T-cell	NULL
clones	NULL
is	NULL
a	NULL
function	NULL
of	NULL
the	NULL
concentration	NULL
of	NULL
antigen	NULL
and	NULL
Ta	NULL
antigens	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

80:6019-6023	NULL
.	NULL

Hatzopoulous	NULL
,	NULL
AK	NULL
.	NULL

,	NULL
A.S.	NULL
Stoykova	NULL
,	NULL
J.R.	NULL
Erselius	NULL
,	NULL
M.	NULL
Goulding	NULL
,	NULL
T.	NULL
Neuman	NULL
,	NULL
and	NULL
P.	NULL
Gruss	NULL
.	NULL

1990	NULL
.	NULL

Structure	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
mouse	NULL
Oct2a	NULL
and	NULL
OctZb	NULL
,	NULL
two	NULL
differentially	NULL
spliced	NULL
products	NULL
of	NULL
the	NULL
same	NULL
gene	NULL
.	NULL

Development	NULL
(	NULL
Camb	NULL
)	NULL
.	NULL

109:349-362	NULL
.	NULL

Tanaka	NULL
,	NULL
M.	NULL
,	NULL
J.-S.	NULL
Lai	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1992	NULL
.	NULL

Promoter-selective	NULL
activation	NULL
domains	NULL
in	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
direct	NULL
differential	NULL
activation	NULL
of	NULL
an	NULL
snRNA	NULL
promoter	NULL
.	NULL

Cell	NULL
.	NULL

68:755-767	NULL
.	NULL

Grueneberg	NULL
,	NULL
D.A	NULL
,	NULL
S.	NULL
Natesan	NULL
,	NULL
C.	NULL
Alexandre	NULL
,	NULL
and	NULL
M.Z	NULL
.	NULL

Gilman	NULL
.	NULL

1992	NULL
.	NULL

Human	NULL
and	NULL
Drosophila	NULL
homeodomain	NULL
proteins	NULL
that	NULL
enhance	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
serum	NULL
phox1	NULL
response	NULL
factor	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

257:1089-1095	NULL
.	NULL

Onate	NULL
,	NULL
$	NULL
.0.	NULL
,	NULL
P.	NULL
Prendergast	NULL
,	NULL
J.P.	NULL
Wagner	NULL
,	NULL
M.	NULL
Nissen	NULL
,	NULL
R.	NULL
Reeves	NULL
,	NULL
D.E	NULL
.	NULL

Pettijohn	NULL
,	NULL
and	NULL
D.P	NULL
.	NULL

Edwards	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
DNA-bending	NULL
protein	NULL
HMG-1	NULL
enhances	NULL
progesterone	NULL
receptor	NULL
binding	NULL
to	NULL
its	NULL
target	NULL
DNA	NULL
sequences	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:3376-3391	NULL
.	NULL

Strauss	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
A.	NULL
Varshavsky	NULL
.	NULL

1984	NULL
.	NULL

A	NULL
protein	NULL
binds	NULL
to	NULL
a	NULL
satellite	NULL
DNA	NULL
repeat	NULL
at	NULL
three	NULL
specific	NULL
sites	NULL
that	NULL
would	NULL
be	NULL
brought	NULL
into	NULL
mutual	NULL
proximity	NULL
by	NULL
DNA	NULL
folding	NULL
in	NULL
the	NULL
nucleosome	NULL
.	NULL

Cell	NULL
.	NULL

37:889-901	NULL
.	NULL

Wegner	NULL
,	NULL
M.	NULL
,	NULL
G.	NULL
Zastrow	NULL
,	NULL
A.	NULL
,	NULL
Klavinius	NULL
,	NULL
S.	NULL
Schwender	NULL
,	NULL
F.	NULL
Muller	NULL
,	NULL
H.	NULL
Luksza	NULL
,	NULL
J.	NULL
Hoppe	NULL
,	NULL
J.	NULL
Wienberg	NULL
,	NULL
and	NULL
F.	NULL
Grummt	NULL
.	NULL

1989	NULL
.	NULL

Cis-acting	NULL
sequences	NULL
from	NULL
mouse	NULL
rDNA	NULL
promote	NULL
plasmid	NULL
DNA	NULL
amplification	NULL
and	NULL
persistence	NULL
in	NULL
mouse	NULL
cells	NULL
:	NULL
implication	NULL
of	NULL
HMG-I	NULL
in	NULL
their	NULL
function	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:9909-9932	NULL
.	NULL

Yang-Yen	NULL
,	NULL
H.F.	NULL
,	NULL
J.C.	NULL
Chambard	NULL
,	NULL
Y.L	NULL
.	NULL

Sun	NULL
,	NULL
T.	NULL
Smeal	NULL
,	NULL
TJ	NULL
.	NULL

Schmidt	NULL
,	NULL
J.	NULL
Drouin	NULL
,	NULL
and	NULL
M.	NULL
Kasir	NULL
.	NULL

1990	NULL
.	NULL

Transcriptional	NULL
interference	NULL
between	NULL
c-jun	NULL
and	NULL
the	NULL
glucocortocoid	NULL
receptor	NULL
:	NULL
mutual	NULL
inhibition	NULL
of	NULL
DNA	NULL
binding	NULL
due	NULL
to	NULL
protein-protein	NULL
interaction	NULL
.	NULL

Cell	NULL
.	NULL

62:1205-1215	NULL
.	NULL

Fashena	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
R.	NULL
Reeves	NULL
,	NULL
and	NULL
N.H.	NULL
Ruddle	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
poly	NULL
(	NULL
dA-dT	NULL
)	NULL
upstream	NULL
activating	NULL
sequence	NULL
binds	NULL
high	NULL
mobility	NULL
group	NULL
I	NULL
protein	NULL
and	NULL
contributes	NULL
to	NULL
lymphotoxin	NULL
(	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
$	NULL
3	NULL
)	NULL
gene	NULL
regulation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:894-903	NULL
.	NULL

Zhao	NULL
,	NULL
K.	NULL
,	NULL
E.	NULL
Kis	NULL
,	NULL
E.	NULL
Gonzalez	NULL
,	NULL
and	NULL
U.K.	NULL
Laemmli	NULL
.	NULL

1993	NULL
.	NULL

SAR-dependent	NULL
mobilization	NULL
of	NULL
histone	NULL
H1	NULL
by	NULL
HMG-I/Y	NULL
in	NULL
vitro	NULL
:	NULL
HMG-I/Y	NULL
is	NULL
enriched	NULL
in	NULL
H1	NULL
depleted	NULL
chromatin	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

12:3237-3247	NULL
.	NULL

Chuvpilo	NULL
,	NULL
S.	NULL
,	NULL
C.	NULL
Schomberg	NULL
,	NULL
R.	NULL
Gerwig	NULL
,	NULL
A.	NULL
Heinfling	NULL
,	NULL
R.	NULL
Reeves	NULL
,	NULL
F.	NULL
Grummt	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1994	NULL
.	NULL

Multiple	NULL
closely-linked	NULL
NFAT/octamer	NULL
and	NULL
HMG	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
binding	NULL
sites	NULL
are	NULL
part	NULL
of	NULL
the	NULL
interleukin-4	NULL
promoter	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:5694-5704	NULL
.	NULL

Steimei	NULL
,	NULL
V.	NULL
,	NULL
L.A.	NULL
Otten	NULL
,	NULL
M.	NULL
Zufferey	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1993	NULL
.	NULL

Com-plementation	NULL
cloning	NULL
of	NULL
an	NULL
MHC	NULL
class	NULL
II	NULL
transactivator	NULL
mutated	NULL
in	NULL
hereditary	NULL
MHC	NULL
class	NULL
II	NULL
deficiency	NULL
(	NULL
or	NULL
Bare	NULL
Lymphocyte	NULL
Syndrome	NULL
)	NULL
.	NULL

Cell	NULL
.	NULL

75:135-146	NULL
.	NULL

Roles	NULL
of	NULL
High	NULL
Mobility	NULL
Group	NULL
Protein	NULL
I/Y	NULL
and	NULL
Oct-2	NULL
in	NULL
HLA-DRA	NULL
Transcription	NULL

